rank | geneset | description | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA02010_ABC_TRANSPORTERS_ GENERAL | Genes involved in ABC transporters - general | 42 | ABCA13(14), ABCA3(4), ABCA4(3), ABCA6(3), ABCA7(2), ABCB1(3), ABCC1(1), ABCC10(1), ABCC12(5), ABCC2(1), ABCC3(3), ABCC5(2), ABCC8(5), ABCC9(5), ABCG4(2), ABCG5(2), ABCG8(1), TAP2(1) | 519552 | 58 | 41 | 58 | 12 | 18 | 18 | 11 | 4 | 7 | 0.000080 | 0.046 |
2 | MONOCYTEPATHWAY | Monocytes are a class of immune phagocytes that can develop into macrophages and express LFA-1, CD44, and other surface signaling proteins. | 10 | ITGAL(6), ITGAM(3), SELE(3) | 64350 | 12 | 9 | 12 | 3 | 5 | 2 | 1 | 2 | 2 | 0.00022 | 0.046 |
3 | NEUTROPHILPATHWAY | Neutrophils are phagocytotic leukocytes that destroy foreign cells with reactive oxygen species or enzymatic digestion and express CD11 and CD18. | 8 | ITGAL(6), ITGAM(3), SELE(3) | 64350 | 12 | 9 | 12 | 3 | 5 | 2 | 1 | 2 | 2 | 0.00022 | 0.046 |
4 | LAIRPATHWAY | The local acute inflammatory response is mediated by activated macrophages and mast cells or by complement activation. | 15 | C3(2), C6(2), C7(3), ITGAL(6) | 64791 | 13 | 12 | 13 | 3 | 4 | 5 | 1 | 2 | 1 | 0.00035 | 0.048 |
5 | HSA04670_LEUKOCYTE_ TRANSENDOTHELIAL_ MIGRATION | Genes involved in Leukocyte transendothelial migration | 110 | ACTN3(2), CDH5(1), CTNND1(3), CYBB(1), GRLF1(3), ITGAL(6), ITGAM(3), MYL7(1), PIK3R5(2), PRKCA(2), PTK2(2), PTK2B(2), RHOH(2) | 290756 | 30 | 23 | 30 | 10 | 12 | 10 | 2 | 5 | 1 | 0.00039 | 0.048 |
6 | HSA00680_METHANE_ METABOLISM | Genes involved in methane metabolism | 10 | TPO(6) | 22127 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0011 | 0.074 |
7 | HSA00940_PHENYLPROPANOID_ BIOSYNTHESIS | Genes involved in phenylpropanoid biosynthesis | 7 | TPO(6) | 22127 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0011 | 0.074 |
8 | BLYMPHOCYTEPATHWAY | B cells express the major histocompatibility complex (class II MHC), immunoglobulins, adhesion proteins, and other factors on their cell surface. | 10 | CR1(3), ITGAL(6), PTPRC(6) | 90809 | 15 | 14 | 15 | 1 | 6 | 4 | 2 | 1 | 2 | 0.0011 | 0.074 |
9 | GPCRDB_CLASS_C_METABOTROPIC_ GLUTAMATE_PHEROMONE | 12 | CASR(4), GRM2(2) | 17756 | 6 | 6 | 6 | 0 | 3 | 2 | 1 | 0 | 0 | 0.0012 | 0.074 | |
10 | AGPCRPATHWAY | G-protein coupled receptors (GPCRs) transduce extracellular signals across the plasma membrane; attenuation occurs by signal molecule degradation or receptor-mediated endocytosis. | 11 | GNAS(3), PRKCA(2) | 17733 | 5 | 5 | 5 | 3 | 3 | 0 | 2 | 0 | 0 | 0.0013 | 0.074 |
11 | HBXPATHWAY | Hbx is a hepatitis B protein that activates a number of transcription factors, possibly by inducing calcium release from the mitochondrion to the cytoplasm. | 8 | CREB1(1), PTK2B(2), SOS1(3) | 20216 | 6 | 6 | 6 | 1 | 1 | 2 | 2 | 1 | 0 | 0.0014 | 0.074 |
12 | TCYTOTOXICPATHWAY | Cytotoxic T cells release perforin and granzyme to lyse foreign cell targets and express Fas ligand to promote Fas-induced apoptosis. | 11 | ITGAL(6), PTPRC(6) | 71397 | 12 | 11 | 12 | 1 | 5 | 3 | 1 | 1 | 2 | 0.0017 | 0.074 |
13 | THELPERPATHWAY | Helper T cells coordinate the actions of B cells, macrophages, and other immune cells via surface molecules such as T cell receptor/CD3 and their characteristic marker CD4. | 11 | ITGAL(6), PTPRC(6) | 71397 | 12 | 11 | 12 | 1 | 5 | 3 | 1 | 1 | 2 | 0.0017 | 0.074 |
14 | HSA04912_GNRH_SIGNALING_ PATHWAY | Genes involved in GnRH signaling pathway | 89 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), CACNA1D(6), CACNA1F(2), CAMK2A(1), CAMK2B(3), CAMK2D(1), GNA11(1), GNAS(3), ITPR1(2), ITPR3(4), MAP2K4(1), MAP2K6(1), PLA2G4A(3), PLCB4(3), PRKCA(2), PTK2B(2), SOS1(3) | 517905 | 51 | 35 | 51 | 17 | 15 | 15 | 13 | 2 | 6 | 0.0019 | 0.074 |
15 | STRIATED_MUSCLE_ CONTRACTION | 35 | ACTN3(2), MYBPC2(1), MYBPC3(3), MYH6(7), MYH7(5), MYH8(10), MYOM1(2), NEB(10), TPM2(1), TPM4(1) | 414473 | 42 | 34 | 42 | 15 | 7 | 20 | 7 | 2 | 6 | 0.0021 | 0.074 | |
16 | CYTOKINEPATHWAY | Intercellular signaling in the immune system occurs via secretion of cytokines, which promote antigen-dependent B and T cell response. | 20 | IL16(5) | 22430 | 5 | 5 | 5 | 0 | 0 | 4 | 0 | 1 | 0 | 0.0023 | 0.074 |
17 | LYMPHOCYTEPATHWAY | B and T cell lymphocytes interact with other cells via transmembrane adhesion proteins such as CD44, which interacts with endothelial cells. | 9 | ITGAL(6), SELE(3) | 58230 | 9 | 7 | 9 | 0 | 3 | 1 | 1 | 2 | 2 | 0.0023 | 0.074 |
18 | HSA04530_TIGHT_JUNCTION | Genes involved in tight junction | 126 | ACTN3(2), ASH1L(3), CDK4(1), EPB41L1(2), INADL(1), LLGL1(1), MAGI1(3), MPDZ(2), MYH1(10), MYH10(3), MYH11(5), MYH4(8), MYH6(7), MYH7(5), MYH8(10), MYL7(1), PARD3(1), PPM1J(1), PPP2R2A(2), PRKCA(2), PRKCE(1), SPTAN1(3), SYMPK(2), YES1(3), ZAK(2) | 953215 | 81 | 51 | 81 | 22 | 15 | 34 | 18 | 3 | 11 | 0.0024 | 0.074 |
19 | CTLPATHWAY | Cytotoxic T lymphocytes induce apoptosis in infected cells presenting antigen-MHC-I complexes via the perforin and Fas/Fas ligand pathways. | 10 | ITGAL(6) | 32947 | 6 | 5 | 6 | 0 | 3 | 0 | 1 | 1 | 1 | 0.0024 | 0.074 |
20 | MYOSINPATHWAY | Myosin light chain kinase phosphorylates myosin and promotes muscle contraction and platelet formation; myosin phosphatase antagonizes these processes. | 12 | MYLK(4), PPP1R12B(2), PRKCA(2) | 37653 | 8 | 8 | 8 | 3 | 3 | 4 | 0 | 0 | 1 | 0.0025 | 0.074 |
21 | CREBPATHWAY | CREB is a transcription factor that binds to cAMP-responsive elements (CREs) to activate transcription in response to extracellular signaling. | 26 | CAMK2A(1), CAMK2B(3), CAMK2D(1), CREB1(1), GNAS(3), PRKCA(2), SOS1(3) | 108100 | 14 | 11 | 14 | 6 | 6 | 1 | 5 | 1 | 1 | 0.0026 | 0.074 |
22 | METPATHWAY | The hepatocyte growth factor receptor c-Met stimulates proliferation and alters cell motility and adhesion on binding the ligand HGF. | 35 | DOCK1(4), ITGA1(1), MET(2), PTK2(2), PTK2B(2), RASA1(1), SOS1(3) | 108477 | 15 | 12 | 15 | 6 | 3 | 3 | 6 | 0 | 3 | 0.0027 | 0.074 |
23 | ACTINYPATHWAY | The Arp 2/3 complex localizes to the Y-junction of polymerizing actin fibers that enable lamellipod extension and consequent cell motility. | 18 | NTRK1(4), WASF1(2), WASF3(1), WASL(2) | 113289 | 9 | 9 | 8 | 1 | 0 | 2 | 0 | 3 | 4 | 0.0027 | 0.074 |
24 | HSA04360_AXON_GUIDANCE | Genes involved in axon guidance | 122 | ABLIM1(1), ABLIM3(3), EPHA3(4), EPHA6(10), EPHB2(1), EPHB4(1), MET(2), NFAT5(2), NFATC3(2), PLXNA1(4), PLXNC1(3), PPP3CC(1), PTK2(2), RASA1(1), ROBO3(5), SEMA4F(1), SEMA4G(1), SEMA6A(3), SEMA6B(1), SEMA7A(1), SLIT1(6), SRGAP3(3) | 629106 | 58 | 38 | 58 | 20 | 19 | 23 | 10 | 2 | 4 | 0.0030 | 0.076 |
25 | VITCBPATHWAY | Vitamin C (ascorbic acid), in addition to its role in collagen modification, serves as an antioxidant and is imported into cells by Svct2 in the brain and Svct1 in intestinal epithelium. | 10 | COL4A1(2), COL4A3(1), COL4A4(5) | 40493 | 8 | 6 | 8 | 7 | 3 | 2 | 1 | 0 | 2 | 0.0032 | 0.077 |
26 | BIOPEPTIDESPATHWAY | Extracellular signaling peptides exert biological effects via G-protein coupled receptors (GPCRs), which activate intracellular GTPases. | 37 | CAMK2A(1), CAMK2B(3), CAMK2D(1), GNA11(1), JAK2(1), MYLK(4), PRKCA(2), PTK2B(2), SOS1(3), STAT1(2) | 149981 | 20 | 15 | 20 | 6 | 7 | 8 | 4 | 0 | 1 | 0.0033 | 0.077 |
27 | AKAP13PATHWAY | A-kinase anchor protein 13 (AKAP13) localizes protein kinase A holoenzyme and is a nucleotide exchange factor for Rho/Rac. | 7 | AKAP13(5) | 19560 | 5 | 5 | 5 | 0 | 1 | 1 | 1 | 0 | 2 | 0.0034 | 0.077 |
28 | PROSTAGLANDIN_AND_ LEUKOTRIENE_METABOLISM | 31 | PLA2G4A(3), TPO(6) | 53062 | 9 | 8 | 9 | 2 | 1 | 5 | 1 | 2 | 0 | 0.0040 | 0.087 | |
29 | CFTRPATHWAY | The cAMP-regulated chloride channel CFTR (deficient in cystic fibrosis) is regulated by the surface-localized beta-adrenergic receptor. | 11 | GNAS(3) | 8640 | 3 | 3 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0.0042 | 0.087 |
30 | HSA04720_LONG_TERM_ POTENTIATION | Genes involved in long-term potentiation | 60 | ADCY8(7), ARAF(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), CREBBP(2), GRIA1(3), ITPR1(2), ITPR3(4), PLCB4(3), PPP3CC(1), PRKCA(2), RPS6KA2(1) | 316735 | 34 | 24 | 34 | 13 | 11 | 13 | 5 | 1 | 4 | 0.0043 | 0.087 |
31 | ALTERNATIVEPATHWAY | The alternative complement pathway is an antibody-independent mechanism of immune activation that results in cell lysis via the membrane attack complex. | 6 | C3(2), C6(2), C7(3), C9(1) | 51796 | 8 | 8 | 8 | 5 | 1 | 6 | 0 | 1 | 0 | 0.0047 | 0.093 |
32 | ACE2PATHWAY | Angiotensin-converting enzyme 2 (ACE2) digests the blood-pressure regulator angiotensin II (AGT) ultimately to the vasodilator AGT1-7. | 11 | ACE2(1), COL4A1(2), COL4A3(1), COL4A4(5), REN(1) | 62015 | 10 | 8 | 10 | 8 | 4 | 2 | 2 | 0 | 2 | 0.0054 | 0.10 |
33 | HSA00563_GLYCOSYLPHOSPHATIDYLINOSITOL_ ANCHOR_BIOSYNTHESIS | Genes involved in glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 23 | PIGG(1), PIGO(2) | 12351 | 3 | 3 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0.0056 | 0.10 |
34 | HSA00061_FATTY_ACID_ BIOSYNTHESIS | Genes involved in fatty acid biosynthesis | 5 | ACACA(2), ACACB(4) | 35160 | 6 | 6 | 6 | 2 | 1 | 1 | 2 | 2 | 0 | 0.0062 | 0.11 |
35 | SIG_CHEMOTAXIS | Genes related to chemotaxis | 43 | ARHGEF11(2), BTK(4), ITPR1(2), ITPR3(4), MYLK(4), RHO(1), WASF1(2), WASL(2) | 234643 | 21 | 16 | 21 | 3 | 3 | 7 | 2 | 5 | 4 | 0.0069 | 0.12 |
36 | METHANE_METABOLISM | 13 | TPO(6) | 33764 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0072 | 0.12 | |
37 | STILBENE_COUMARINE_ AND_LIGNIN_BIOSYNTHESIS | 10 | TPO(6) | 33764 | 6 | 6 | 6 | 2 | 0 | 4 | 0 | 2 | 0 | 0.0072 | 0.12 | |
38 | GPCRPATHWAY | G-protein coupled receptors activate adenylyl cyclase, which converts ATP to cAMP, to activate second messenger pathways. | 34 | CREB1(1), GNAS(3), NFATC3(2), PPP3CC(1), PRKCA(2) | 77814 | 9 | 7 | 9 | 4 | 4 | 0 | 3 | 2 | 0 | 0.0074 | 0.12 |
39 | SALMONELLAPATHWAY | Salmonella induces membrane ruffling in infected cells via bacterial proteins including SipA, SipC, and SopE, which alter actin structure. | 12 | WASF1(2), WASL(2) | 50763 | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 3 | 1 | 0.0079 | 0.12 |
40 | HSA04664_FC_EPSILON_ RI_SIGNALING_PATHWAY | Genes involved in Fc epsilon RI signaling pathway | 73 | BTK(4), INPP5D(1), LAT(1), LYN(1), MAP2K4(1), MAP2K6(1), MS4A2(1), PIK3R5(2), PLA2G4A(3), PRKCA(2), PRKCE(1), SOS1(3) | 190730 | 21 | 19 | 21 | 5 | 6 | 5 | 7 | 0 | 3 | 0.0085 | 0.13 |
41 | TRKAPATHWAY | Nerve growth factor (NGF) promotes neuronal survival and proliferation by binding its receptor TrkA, which activates PI3K/AKT, Ras, and the MAP kinase pathway. | 12 | NTRK1(4), PRKCA(2), SOS1(3) | 55428 | 9 | 8 | 8 | 3 | 3 | 2 | 2 | 0 | 2 | 0.0086 | 0.13 |
42 | ACHPATHWAY | Nicotinic acetylcholine receptors are ligand-gated ion channels that primarily mediate neuromuscular signaling and may inhibit neuronal apoptosis via the AKT pathway. | 13 | PTK2(2), PTK2B(2), TERT(1) | 24506 | 5 | 5 | 5 | 1 | 0 | 4 | 1 | 0 | 0 | 0.0090 | 0.13 |
43 | AMIPATHWAY | Endogenous anti-thrombosis pathways are overwhelmed in plaque-narrowed blood vessels, resulting in potentially lethal myocardial infarction. | 21 | CREBBP(2), GNAS(3), PTPRC(6) | 68826 | 11 | 11 | 11 | 4 | 3 | 4 | 2 | 0 | 2 | 0.0094 | 0.13 |
44 | CSKPATHWAY | Csk inhibits T-cell activation by phosphorylating Lck; Csk is regulated by cAMP-dependent kinases and is opposed by the T-cell activator CD45. | 21 | CREBBP(2), GNAS(3), PTPRC(6) | 68826 | 11 | 11 | 11 | 4 | 3 | 4 | 2 | 0 | 2 | 0.0094 | 0.13 |
45 | TYROSINE_METABOLISM | 32 | ADH1B(4), ADH6(2), ALDH3A1(1), AOC2(1), DDC(2), TAT(1), TPO(6) | 142384 | 17 | 16 | 17 | 4 | 4 | 8 | 1 | 2 | 2 | 0.010 | 0.14 | |
46 | CCR5PATHWAY | CCR5 is a G-protein coupled receptor expressed in macrophages that recognizes chemokine ligands and is targeted by the HIV envelope protein GP120. | 17 | PRKCA(2), PTK2B(2) | 13893 | 4 | 4 | 4 | 1 | 2 | 2 | 0 | 0 | 0 | 0.011 | 0.15 |
47 | IONPATHWAY | Activated phospholipase C hydrolyzes the lipid PIP3 into second messengers DAG, which activates protein kinase C, and IP3, which induces calcium influx into the cytoplasm. | 4 | PRKCA(2), PTK2B(2) | 13893 | 4 | 4 | 4 | 1 | 2 | 2 | 0 | 0 | 0 | 0.011 | 0.15 |
48 | HSA04540_GAP_JUNCTION | Genes involved in gap junction | 86 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), GNA11(1), GNAS(3), GUCY2C(3), ITPR1(2), ITPR3(4), PDGFRB(3), PLCB4(3), PRKCA(2), SOS1(3), TUBA4A(1), TUBB4(1) | 448981 | 39 | 27 | 39 | 18 | 12 | 9 | 10 | 3 | 5 | 0.012 | 0.15 |
49 | NDKDYNAMINPATHWAY | Endocytotic role of NDK, Phosphins and Dynamin | 19 | AMPH(3), PICALM(2), PPP3CC(1), SYNJ2(1) | 43532 | 7 | 6 | 7 | 2 | 4 | 1 | 2 | 0 | 0 | 0.012 | 0.15 |
50 | ST_PHOSPHOINOSITIDE_ 3_KINASE_PATHWAY | The phosphoinositide-3 kinase pathway produces the lipid second messenger PIP3 and regulates cell growth, survival, and movement. | 33 | BTK(4), INPP5D(1), RPS6KA2(1), SOS1(3) | 58818 | 9 | 9 | 9 | 1 | 1 | 3 | 3 | 0 | 2 | 0.012 | 0.15 |
51 | ST_MYOCYTE_AD_PATHWAY | Cardiac myocytes have a variety of adrenergic receptors that induce subtype-specific signaling effects. | 21 | APC(4), EPHB2(1), ITPR1(2), ITPR3(4), RHO(1) | 111602 | 12 | 10 | 12 | 2 | 1 | 6 | 1 | 3 | 1 | 0.013 | 0.16 |
52 | RIBOFLAVIN_METABOLISM | 10 | ACP5(2), ACPP(1), ENPP3(2) | 24595 | 5 | 5 | 5 | 0 | 3 | 2 | 0 | 0 | 0 | 0.016 | 0.18 | |
53 | GSPATHWAY | Activated G-protein coupled receptors stimulate cAMP production and thus activate protein kinase A, involved in a number of signal transduction pathways. | 6 | GNAS(3) | 13639 | 3 | 3 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0.018 | 0.20 |
54 | NKTPATHWAY | T cell differentiation into Th1 and Th2 cells occurs by differential chemokine receptor expression, which mediates tissue localization and immune response. | 28 | CXCR3(1), IL12RB2(2) | 17139 | 3 | 2 | 3 | 1 | 1 | 0 | 0 | 1 | 1 | 0.019 | 0.22 |
55 | ST_INTERFERON_GAMMA_ PATHWAY | The interferon gamma pathway resembles the JAK-STAT pathway and activates STAT transcription factors. | 9 | JAK1(1), JAK2(1), PTPRU(3), STAT1(2) | 48570 | 7 | 7 | 7 | 1 | 1 | 5 | 0 | 1 | 0 | 0.020 | 0.22 |
56 | CHREBPPATHWAY | Carbohydrate responsive element binding protein (chREBP) is a transcription factor inhibited by cAMP and activated by high carbohydrate levels. | 17 | GNAS(3), PRKAG2(1) | 20280 | 4 | 4 | 4 | 2 | 2 | 0 | 2 | 0 | 0 | 0.020 | 0.22 |
57 | PANTOTHENATE_AND_ COA_BIOSYNTHESIS | 12 | DPYS(3), ENPP3(2), PANK3(1), PANK4(1) | 47188 | 7 | 7 | 7 | 2 | 3 | 3 | 0 | 1 | 0 | 0.021 | 0.23 | |
58 | ST_TYPE_I_INTERFERON_ PATHWAY | Type I interferon is an antiviral cytokine that induces a JAK-STAT type pathway leading to ISGF3 activation and a cellular antiviral response. | 8 | JAK1(1), PTPRU(3), STAT1(2), STAT2(2) | 54517 | 8 | 8 | 8 | 1 | 2 | 4 | 0 | 1 | 1 | 0.022 | 0.23 |
59 | HSA00950_ALKALOID_ BIOSYNTHESIS_I | Genes involved in alkaloid biosynthesis I | 5 | DDC(2), TAT(1) | 11696 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | 0 | 1 | 0.024 | 0.25 |
60 | SIG_PIP3_SIGNALING_ IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes | 32 | BCR(1), BTK(4), ITPR1(2), ITPR3(4), LYN(1), PTPRC(6), RPS6KA2(1) | 193220 | 19 | 15 | 19 | 3 | 3 | 9 | 2 | 1 | 4 | 0.026 | 0.27 |
61 | BILE_ACID_BIOSYNTHESIS | 27 | ADH1B(4), ADH6(2), ALDH3A1(1), HADHB(3) | 67844 | 10 | 10 | 10 | 1 | 4 | 3 | 2 | 0 | 1 | 0.028 | 0.28 | |
62 | ST_G_ALPHA_I_PATHWAY | Gi and Go proteins are members of the same family that transduce cellular signals through both their alpha and beta subunits. | 30 | EPHB2(1), ITPR1(2), ITPR3(4), PLCB4(3), SOS1(3) | 99858 | 13 | 10 | 13 | 2 | 3 | 6 | 2 | 1 | 1 | 0.029 | 0.28 |
63 | PLCDPATHWAY | Phospholipase C (PLC-d1) hydrolyzes the membrane lipid PIP2 to DAG and IP3, which induce calcium influx and activates protein kinase C. | 4 | PLCD1(1), PRKCA(2) | 21033 | 3 | 3 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0.029 | 0.29 |
64 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. | 15 | NTRK1(4), SOS1(3) | 50055 | 7 | 7 | 6 | 2 | 1 | 2 | 2 | 0 | 2 | 0.030 | 0.29 |
65 | NO2IL12PATHWAY | Macrophages activate NK cells by releasing IL-12, which induces NK cytotoxic activity in coordination with NO produced by inducible nitric oxide synthase II. | 15 | CXCR3(1), IL12RB2(2), JAK2(1) | 25504 | 4 | 2 | 4 | 1 | 1 | 1 | 0 | 1 | 1 | 0.032 | 0.30 |
66 | ST_WNT_CA2_CYCLIC_ GMP_PATHWAY | Some Wnt glycoprotein/Frizzled receptor interactions increase intracellular calcium and decrease cGMP. | 17 | CAMK2A(1), CAMK2B(3), CAMK2D(1), ITPR1(2), ITPR3(4), NFAT5(2), PDE6C(2) | 135004 | 15 | 11 | 15 | 3 | 3 | 6 | 2 | 1 | 3 | 0.033 | 0.31 |
67 | ST_JAK_STAT_PATHWAY | The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway transduces extracellular signals to promote gene activation. | 9 | JAK1(1), JAK2(1), PIAS1(1), PTPRU(3) | 43100 | 6 | 6 | 6 | 0 | 1 | 4 | 0 | 1 | 0 | 0.034 | 0.32 |
68 | CBLPATHWAY | Activated EGF receptors undergo endocytosis into clathrin-coated vesicles, where they are recycled to the membrane or ubiquitinated by Cbl. | 11 | CSF1R(2), MET(2), PRKCA(2) | 45665 | 6 | 6 | 6 | 5 | 3 | 0 | 2 | 0 | 1 | 0.035 | 0.32 |
69 | PTDINSPATHWAY | Phosphoinositide 3 kinase (PI3K) phosphorylate inositol rings of phosphoinositide lipids, influencing vesicle trafficking, cell proliferation, and migration. | 22 | BTK(4), LYN(1), PFKP(1), PRKCE(1) | 75538 | 7 | 7 | 7 | 1 | 0 | 1 | 3 | 1 | 2 | 0.037 | 0.33 |
70 | TH1TH2PATHWAY | Helper T subtype Th1 produces pro-inflammatory cytokines that stimulate phagocytosis, while Th2 cells promote antibody production and activate eosinophils. | 17 | IL12RB2(2) | 14606 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 0.038 | 0.33 |
71 | STARCH_AND_SUCROSE_ METABOLISM | 44 | AGL(3), ENPP3(2), GANAB(1), GCK(2), GPI(2), GYS2(2), HK1(1), MGAM(6), UGT2B15(1) | 241786 | 20 | 17 | 20 | 5 | 5 | 12 | 1 | 2 | 0 | 0.039 | 0.33 | |
72 | TCRAPATHWAY | The kinases Lck and Fyn phosphorylate and activate the T cell receptor, which recognizes antigen-bound MHCII and leads to T cell activation. | 10 | PTPRC(6) | 40162 | 6 | 6 | 6 | 1 | 2 | 3 | 0 | 0 | 1 | 0.039 | 0.33 |
73 | IL12PATHWAY | IL12 and Stat4 Dependent Signaling Pathway in Th1 Development | 20 | CXCR3(1), IL12RB2(2), JAK2(1), MAP2K6(1) | 35824 | 5 | 3 | 5 | 1 | 1 | 2 | 0 | 1 | 1 | 0.041 | 0.34 |
74 | ERKPATHWAY | Cell growth is promoted by Ras activation of the anti-apoptotic p44/42 MAP kinase pathway. | 28 | GNAS(3), SOS1(3) | 62842 | 6 | 6 | 6 | 4 | 2 | 0 | 4 | 0 | 0 | 0.041 | 0.34 |
75 | DCPATHWAY | Dendritic cells internalize and present antigen, after which they migrate to lymphocyte-rich tissues and induce T and B cell differentiation. | 21 | CD5(2), TLR9(3) | 34982 | 5 | 4 | 5 | 0 | 0 | 2 | 1 | 1 | 1 | 0.043 | 0.35 |
76 | ST_STAT3_PATHWAY | The transcription factor STAT3 is involved in cell growth regulation and is commonly upregulated in tumors. | 11 | JAK1(1), JAK2(1), PTPRU(3) | 41370 | 5 | 5 | 5 | 0 | 0 | 4 | 0 | 1 | 0 | 0.046 | 0.37 |
77 | HSA00062_FATTY_ACID_ ELONGATION_IN_MITOCHONDRIA | Genes involved in fatty acid elongation in mitochondria | 10 | HADHB(3), HSD17B4(2) | 42076 | 5 | 5 | 5 | 0 | 3 | 0 | 1 | 1 | 0 | 0.046 | 0.37 |
78 | HSA04916_MELANOGENESIS | Genes involved in melanogenesis | 96 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), CAMK2A(1), CAMK2B(3), CAMK2D(1), CREB1(1), CREB3L3(1), CREBBP(2), DVL1(1), DVL3(3), FZD2(1), GNAS(3), PLCB4(3), PRKCA(2), WNT7A(3) | 508734 | 38 | 32 | 38 | 15 | 12 | 10 | 7 | 2 | 7 | 0.047 | 0.37 |
79 | IFNAPATHWAY | Interferon alpha, active in the immune response, binds to the IFN receptor and activates Jak1 and Tyk2, which phosphorylate Stat1 and Stat2. | 8 | JAK1(1), STAT1(2), STAT2(2) | 39605 | 5 | 5 | 5 | 1 | 2 | 1 | 0 | 1 | 1 | 0.048 | 0.37 |
80 | HSA04370_VEGF_SIGNALING_ PATHWAY | Genes involved in VEGF signaling pathway | 68 | MAPKAPK2(1), NFAT5(2), NFATC3(2), NOS3(1), PIK3R5(2), PLA2G4A(3), PPP3CC(1), PRKCA(2), PTK2(2) | 169428 | 16 | 11 | 16 | 3 | 6 | 4 | 4 | 2 | 0 | 0.051 | 0.39 |
81 | GLYCOLYSISPATHWAY | Glycolysis is an evolutionarily conserved pathway by which one glucose molecule is converted to two pyruvate molecules for a gain of 2 ATP. | 9 | GPI(2), HK1(1), PGK1(2) | 33360 | 5 | 5 | 5 | 2 | 1 | 3 | 0 | 0 | 1 | 0.056 | 0.43 |
82 | BCRPATHWAY | B cell antigen receptors (BCRs) activate tyrosine kinases and transiently increase tyrosine phosphorylation on binding to antigen. | 34 | BLNK(1), BTK(4), LYN(1), NFATC3(2), PPP3CC(1), PRKCA(2), SOS1(3) | 160331 | 14 | 12 | 14 | 4 | 4 | 1 | 6 | 1 | 2 | 0.058 | 0.44 |
83 | GABAPATHWAY | Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter whose receptor is regulated by Plic-1, gephyrin, and GABARAP, which promote receptor clustering. | 12 | GABRA3(2) | 9560 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0.060 | 0.44 |
84 | HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETON | Genes involved in regulation of actin cytoskeleton | 199 | ACTN3(2), APC(4), APC2(1), ARAF(1), ARHGEF6(4), CYFIP2(2), DOCK1(4), FGD1(1), FGD3(3), GRLF1(3), ITGA1(1), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), ITGAD(5), ITGAE(1), ITGAL(6), ITGAM(3), ITGB4(1), MYH10(3), MYL7(1), MYLK(4), NCKAP1L(4), PDGFRB(3), PIK3R5(2), PPP1R12B(2), PTK2(2), SOS1(3), TIAM2(5), WASF1(2), WASL(2) | 1142363 | 86 | 49 | 86 | 24 | 18 | 31 | 19 | 8 | 10 | 0.060 | 0.44 |
85 | ARENRF2PATHWAY | Nrf1 and nrf2 are transcription factors that bind to antioxidant response elements (AREs), promoters of genes involved in oxidative damage control. | 12 | CREB1(1), PRKCA(2) | 24989 | 3 | 3 | 3 | 1 | 2 | 0 | 0 | 1 | 0 | 0.064 | 0.46 |
86 | CALCINEURINPATHWAY | Increased intracellular calcium activates the phosphatase calcineurin in differentiating keratinocytes. | 18 | NFATC3(2), PPP3CC(1), PRKCA(2) | 46745 | 5 | 4 | 5 | 1 | 3 | 0 | 1 | 1 | 0 | 0.065 | 0.46 |
87 | HSA00592_ALPHA_LINOLENIC_ ACID_METABOLISM | Genes involved in alpha-Linolenic acid metabolism | 15 | PLA2G4A(3) | 13658 | 3 | 2 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 0.067 | 0.48 |
88 | FCER1PATHWAY | In mast cells, Fc epsilon receptor 1 activates BTK, PKC, and the MAP kinase pathway to promote degranulation and arachnidonic acid release. | 37 | BTK(4), LYN(1), MAP2K4(1), NFATC3(2), PLA2G4A(3), PPP3CC(1), SOS1(3) | 181074 | 15 | 10 | 15 | 3 | 3 | 2 | 6 | 1 | 3 | 0.070 | 0.49 |
89 | IL10PATHWAY | The cytokine IL-10 inhibits the inflammatory response by macrophages via activation of heme oxygenase 1. | 13 | BLVRB(1), IL10RA(1), JAK1(1), STAT1(2) | 40569 | 5 | 5 | 5 | 1 | 1 | 2 | 0 | 1 | 1 | 0.072 | 0.50 |
90 | RELAPATHWAY | Acetylated NF-kB proteins are immune to IkB regulation and promote transcription until the histone deacetylase HDAC3 deacetylates the RelA subunit of NF-kB. | 16 | CHUK(2), CREBBP(2), TNFRSF1B(1) | 69077 | 5 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 3 | 0.074 | 0.50 |
91 | INTEGRIN_MEDIATED_ CELL_ADHESION_KEGG | 89 | CAPN11(3), CAPN3(1), CAPN5(2), DOCK1(4), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), ITGAD(5), ITGAE(1), ITGAL(6), ITGAM(3), ITGB4(1), MAP2K6(1), PTK2(2), RHO(1), SORBS1(3), SOS1(3), TLN1(3) | 639643 | 50 | 33 | 50 | 15 | 16 | 15 | 10 | 3 | 6 | 0.076 | 0.50 | |
92 | HSA00710_CARBON_ FIXATION | Genes involved in carbon fixation | 23 | PGK1(2), TKTL1(3) | 56254 | 5 | 5 | 5 | 0 | 1 | 0 | 2 | 0 | 2 | 0.076 | 0.50 |
93 | AKTPATHWAY | Second messenger PIP3 promotes cell survival by activating the anti-apoptotic kinase AKT. | 14 | CHUK(2) | 24142 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.076 | 0.50 |
94 | 1_AND_2_METHYLNAPHTHALENE_ DEGRADATION | 7 | ADH1B(4), ADH6(2) | 48028 | 6 | 6 | 6 | 0 | 2 | 3 | 0 | 0 | 1 | 0.077 | 0.50 | |
95 | SA_DIACYLGLYCEROL_ SIGNALING | DAG (diacylglycerol) signaling activity | 9 | PDE1A(1), PDE1B(1) | 7724 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.079 | 0.51 |
96 | TPOPATHWAY | Thrombopoietin binds to its receptor and activates cell growth through the Erk and JNK MAP kinase pathways, protein kinase C, and JAK/STAT activation. | 22 | JAK2(1), PRKCA(2), RASA1(1), SOS1(3), STAT1(2), STAT5B(1) | 96118 | 10 | 9 | 10 | 5 | 5 | 2 | 3 | 0 | 0 | 0.084 | 0.54 |
97 | PHENYLALANINE_METABOLISM | 22 | ALDH3A1(1), AOC2(1), DDC(2), TAT(1), TPO(6) | 105993 | 11 | 11 | 11 | 4 | 2 | 5 | 1 | 2 | 1 | 0.087 | 0.55 | |
98 | HSA00071_FATTY_ACID_ METABOLISM | Genes involved in fatty acid metabolism | 47 | ACSL3(1), ACSL5(1), ADH1B(4), ADH6(2), ALDH3A1(1), EHHADH(1), GCDH(1), HADHB(3), HSD17B4(2) | 171707 | 16 | 15 | 16 | 2 | 7 | 4 | 2 | 1 | 2 | 0.088 | 0.56 |
99 | ST_ADRENERGIC | Adrenergic receptors respond to epinephrine and norepinephrine signaling. | 31 | APC(4), GNA11(1), ITPR1(2), ITPR3(4) | 115352 | 11 | 9 | 11 | 1 | 1 | 5 | 2 | 2 | 1 | 0.093 | 0.58 |
100 | HSA00120_BILE_ACID_ BIOSYNTHESIS | Genes involved in bile acid biosynthesis | 38 | ADH1B(4), ADH6(2), ALDH3A1(1), HADHB(3) | 87384 | 10 | 10 | 10 | 1 | 4 | 3 | 2 | 0 | 1 | 0.095 | 0.58 |
101 | STATIN_PATHWAY_PHARMGKB | 18 | DGAT1(2), HMGCR(1), LDLR(2), LRP1(6) | 129836 | 11 | 11 | 9 | 7 | 2 | 4 | 5 | 0 | 0 | 0.096 | 0.58 | |
102 | GCRPATHWAY | Corticosteroids activate the glucocorticoid receptor (GR), which inhibits NF-kB and activates Annexin-1, thus inhibiting the inflammatory response. | 17 | GNAS(3), NOS3(1) | 46869 | 4 | 4 | 4 | 2 | 1 | 0 | 2 | 1 | 0 | 0.096 | 0.58 |
103 | MRPPATHWAY | Cancer cells resistant to numerous drugs are called multidrug-resistant (MDR) and express ATP-binding cassette transporter proteins that pump the drugs out of cells. | 6 | ABCB1(3), ABCC1(1), ABCC3(3) | 59981 | 7 | 7 | 7 | 4 | 2 | 2 | 1 | 1 | 1 | 0.10 | 0.59 |
104 | HSA00620_PYRUVATE_ METABOLISM | Genes involved in pyruvate metabolism | 41 | ACACA(2), ACACB(4), ACSS1(1), ALDH3A1(1), DLAT(1), GRHPR(1), HAGH(1), LDHC(1), PC(1) | 194290 | 13 | 12 | 13 | 6 | 3 | 2 | 6 | 2 | 0 | 0.10 | 0.59 |
105 | HSA00641_3_CHLOROACRYLIC_ ACID_DEGRADATION | Genes involved in 3-chloroacrylic acid degradation | 15 | ADH1B(4), ADH6(2), ALDH3A1(1) | 54441 | 7 | 7 | 7 | 1 | 2 | 3 | 1 | 0 | 1 | 0.10 | 0.59 |
106 | GALACTOSE_METABOLISM | 24 | GANAB(1), GCK(2), HK1(1), MGAM(6), PFKP(1) | 141663 | 11 | 11 | 11 | 4 | 2 | 5 | 1 | 3 | 0 | 0.10 | 0.59 | |
107 | PPARAPATHWAY | Peroxisome proliferators regulate gene expression via PPAR/RXR heterodimers which bind to peroxisome-proliferator response elements (PPREs). | 50 | CD36(1), CREBBP(2), EHHADH(1), HSD17B4(2), MRPL11(1), NCOR1(1), NCOR2(3), NR1H3(2), PRKCA(2), STAT5B(1) | 193289 | 16 | 14 | 16 | 5 | 5 | 8 | 0 | 2 | 1 | 0.10 | 0.59 |
108 | ST_INTERLEUKIN_4_ PATHWAY | Like IL-13, IL-4 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 26 | INPP5D(1), JAK1(1), JAK2(1), SOS1(3) | 50814 | 6 | 6 | 6 | 1 | 1 | 2 | 2 | 1 | 0 | 0.10 | 0.59 |
109 | FLUMAZENILPATHWAY | Flumazenil is a benzodiazepine receptor antagonist that may induce protective preconditioning in ischemic cardiomyocytes. | 9 | GABRA3(2), PRKCE(1) | 19481 | 3 | 3 | 3 | 2 | 0 | 2 | 1 | 0 | 0 | 0.10 | 0.59 |
110 | CARDIACEGFPATHWAY | Cardiac hypertrophy, a response to high blood pressure, is stimulated by GPCR ligands such as angiotensin II that activate the EGF pathway. | 15 | ADAM12(2), PRKCA(2) | 35416 | 4 | 4 | 4 | 1 | 3 | 1 | 0 | 0 | 0 | 0.11 | 0.59 |
111 | NOS1PATHWAY | Glutamate stimulates NMDA-mediates calcium influx, which promotes nitric oxide synthesis from arginine by neuronal nitric oxide synthase, activating guanylate cyclase. | 20 | PPP3CC(1), PRKCA(2) | 27905 | 3 | 3 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0.11 | 0.59 |
112 | IFNGPATHWAY | IFN gamma signaling pathway | 6 | JAK1(1), JAK2(1), STAT1(2) | 33658 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.11 | 0.59 |
113 | HIFPATHWAY | Under normal conditions, hypoxia inducible factor HIF-1 is degraded; under hypoxic conditions, it activates transcription of genes controlled by hpoxic response elements (HREs). | 13 | CREB1(1), NOS3(1) | 41159 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0.11 | 0.60 |
114 | HSA00591_LINOLEIC_ ACID_METABOLISM | Genes involved in linoleic acid metabolism | 31 | CYP2C19(1), CYP2E1(1), CYP3A7(3), PLA2G4A(3) | 66796 | 8 | 7 | 8 | 2 | 2 | 4 | 1 | 0 | 1 | 0.11 | 0.60 |
115 | HSA04640_HEMATOPOIETIC_ CELL_LINEAGE | Genes involved in hematopoietic cell lineage | 85 | CD1B(2), CD1E(1), CD22(2), CD36(1), CD5(2), CR1(3), CSF1R(2), GP1BA(1), GP5(1), IL5RA(1), ITGA1(1), ITGA2(3), ITGA5(1), ITGAM(3), TPO(6) | 385036 | 30 | 23 | 30 | 15 | 5 | 16 | 3 | 2 | 4 | 0.11 | 0.60 |
116 | PAR1PATHWAY | Activated extracellular thrombin cleaves and activates the G-protein coupled receptors PAR1 and PAR4, which activate platelets. | 18 | PPP1R12B(2), PRKCA(2), PTK2B(2) | 52091 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 0 | 1 | 0.11 | 0.60 |
117 | HSA04730_LONG_TERM_ DEPRESSION | Genes involved in long-term depression | 68 | ARAF(1), CACNA1A(1), GNA11(1), GNAS(3), GRIA1(3), GUCY2C(3), ITPR1(2), ITPR3(4), LYN(1), NOS3(1), PLA2G4A(3), PLCB4(3), PPP2R2A(2), PRKCA(2) | 358837 | 30 | 21 | 30 | 10 | 8 | 10 | 7 | 3 | 2 | 0.11 | 0.60 |
118 | NICOTINATE_AND_NICOTINAMIDE_ METABOLISM | 13 | ENPP3(2), NNMT(1), NNT(1), NT5E(1) | 56159 | 5 | 5 | 5 | 2 | 2 | 0 | 2 | 1 | 0 | 0.12 | 0.60 | |
119 | STEROID_BIOSYNTHESIS | 9 | HSD17B4(2) | 19236 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0.12 | 0.60 | |
120 | ST_GRANULE_CELL_ SURVIVAL_PATHWAY | The survival and differentiation of granule cells in the brain is controlled by pro-growth PACAP and pro-apoptotic ceramides. | 25 | APC(4), CREB1(1), EPHB2(1), MAP2K4(1), MAPK8IP1(1) | 90806 | 8 | 7 | 8 | 1 | 1 | 3 | 1 | 2 | 1 | 0.12 | 0.60 |
121 | VALINE_LEUCINE_AND_ ISOLEUCINE_BIOSYNTHESIS | 7 | LARS(4), LARS2(1) | 43867 | 5 | 5 | 5 | 1 | 1 | 2 | 1 | 1 | 0 | 0.12 | 0.60 | |
122 | LDLPATHWAY | Low density lipoproteins (LDL) are present in blood plasma, contain cholesterol and triglycerides, and contribute to atherogenic plaque formation. | 6 | LDLR(2) | 10336 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0.12 | 0.62 |
123 | HSA03030_DNA_POLYMERASE | Genes involved in DNA polymerase | 23 | POLA2(1), POLD1(2), REV3L(3) | 74706 | 6 | 6 | 6 | 1 | 0 | 2 | 1 | 1 | 2 | 0.13 | 0.62 |
124 | IL7PATHWAY | IL-7 is required for B and T cell development and proliferation and may contribute to activation of VDJ recombination. | 16 | CREBBP(2), JAK1(1), PTK2B(2), STAT5B(1) | 62452 | 6 | 6 | 6 | 1 | 1 | 3 | 0 | 1 | 1 | 0.13 | 0.62 |
125 | TOLLPATHWAY | Toll-like receptors are activated by bacterial lipoproteins, lipopolysaccharides, and other surface molecules, and activate pro-inflammatory factors such as NF-kB. | 32 | CHUK(2), MAP2K4(1), MAP2K6(1), TLR9(3), TOLLIP(1) | 173736 | 8 | 7 | 8 | 0 | 1 | 1 | 1 | 1 | 4 | 0.13 | 0.62 |
126 | SIG_REGULATION_OF_ THE_ACTIN_CYTOSKELETON_ BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton | 34 | ACTG2(2), FLNA(1), MYLK(4), RHO(1), WASF1(2), WASL(2) | 212942 | 12 | 11 | 12 | 2 | 1 | 5 | 1 | 4 | 1 | 0.13 | 0.62 |
127 | HSA00350_TYROSINE_ METABOLISM | Genes involved in tyrosine metabolism | 56 | ADH1B(4), ADH6(2), ALDH3A1(1), AOC2(1), DDC(2), TAT(1), TPO(6) | 199778 | 17 | 16 | 17 | 6 | 4 | 8 | 1 | 2 | 2 | 0.13 | 0.63 |
128 | PKCPATHWAY | Gq-coupled receptors promote hydrolysis of PIP2 to DAG and IP3, which causes calcium influx and activates protein kinase C. | 5 | PRKCA(2) | 16216 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0.13 | 0.63 |
129 | HSA00280_VALINE_ LEUCINE_AND_ISOLEUCINE_ DEGRADATION | Genes involved in valine, leucine and isoleucine degradation | 43 | ALDH3A1(1), BCAT2(2), DBT(1), EHHADH(1), HADHB(3), HSD17B4(2), MCCC2(2) | 127052 | 12 | 12 | 12 | 2 | 3 | 4 | 4 | 1 | 0 | 0.13 | 0.63 |
130 | HSA01040_POLYUNSATURATED_ FATTY_ACID_BIOSYNTHESIS | Genes involved in polyunsaturated fatty acid biosynthesis | 13 | HSD17B12(1) | 2457 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.13 | 0.63 |
131 | CARM1PATHWAY | The methyltransferase CARM1 interacts with transcription factors such as CBP/p300 and methylates histones H3 and H4. | 13 | CREB1(1), CREBBP(2) | 38623 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | 0.13 | 0.63 |
132 | HSA00740_RIBOFLAVIN_ METABOLISM | Genes involved in riboflavin metabolism | 16 | ACP5(2), ACP6(1), ACPP(1), ENPP3(2) | 56508 | 6 | 6 | 6 | 0 | 3 | 3 | 0 | 0 | 0 | 0.13 | 0.63 |
133 | HSA00052_GALACTOSE_ METABOLISM | Genes involved in galactose metabolism | 32 | GCK(2), HK1(1), MGAM(6), PFKP(1) | 138638 | 10 | 10 | 10 | 4 | 2 | 4 | 1 | 3 | 0 | 0.14 | 0.63 |
134 | RNAPATHWAY | dsRNA-activated protein kinase phosphorylates elF2a, which generally inhibits translation, and activates NF-kB to provoke inflammation. | 9 | CHUK(2) | 37195 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.14 | 0.63 |
135 | CREMPATHWAY | The transcription factor CREM activates a post-meiotic transcriptional cascade culminating in spermatogenesis. | 7 | CREM(1), GNAS(3) | 30169 | 4 | 4 | 4 | 2 | 1 | 1 | 2 | 0 | 0 | 0.14 | 0.63 |
136 | PYRUVATE_METABOLISM | 36 | ACACA(2), ALDH3A1(1), DLAT(1), GRHPR(1), HAGH(1), LDHC(1), PC(1) | 136090 | 8 | 8 | 8 | 4 | 1 | 1 | 5 | 1 | 0 | 0.14 | 0.63 | |
137 | FXRPATHWAY | The nuclear receptor transcription factors FXR and LXR are activated by cholesterol metabolites and regulate cholesterol homeostasis. | 6 | LDLR(2), NR1H3(2) | 34212 | 4 | 4 | 4 | 2 | 0 | 4 | 0 | 0 | 0 | 0.14 | 0.63 |
138 | PLCPATHWAY | Phospholipase C hydrolyzes the membrane lipid PIP2 to DAG, which activates protein kinase C, and IP3, which causes calcium influx. | 6 | PRKCA(2) | 16955 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0.14 | 0.63 |
139 | ST_INTEGRIN_SIGNALING_ PATHWAY | Integrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix. | 76 | ARHGEF6(4), DOCK1(4), EPHB2(1), GRLF1(3), ITGA1(1), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), MAP2K4(1), MAPK8IP1(1), MYLK(4), PTK2(2), RHO(1), SOS1(3), TLN1(3), TLN2(3) | 550066 | 42 | 31 | 42 | 12 | 11 | 17 | 7 | 1 | 6 | 0.15 | 0.63 |
140 | D4GDIPATHWAY | D4-GDI inhibits the pro-apoptotic Rho GTPases and is cleaved by caspase-3. | 12 | CASP10(2) | 24240 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 0.15 | 0.63 |
141 | HSA00360_PHENYLALANINE_ METABOLISM | Genes involved in phenylalanine metabolism | 27 | ALDH3A1(1), AOC2(1), DDC(2), TAT(1), TPO(6) | 119803 | 11 | 11 | 11 | 6 | 2 | 5 | 1 | 2 | 1 | 0.15 | 0.63 |
142 | SIG_BCR_SIGNALING_ PATHWAY | Members of the BCR signaling pathway | 45 | BCR(1), BLNK(1), BTK(4), CD22(2), INPP5D(1), ITPR1(2), ITPR3(4), LYN(1), PPP3CC(1), PTPRC(6), SOS1(3) | 328902 | 26 | 21 | 26 | 7 | 5 | 10 | 5 | 1 | 5 | 0.15 | 0.63 |
143 | 1_2_DICHLOROETHANE_ DEGRADATION | 8 | ALDH3A1(1) | 6413 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0.15 | 0.63 | |
144 | ASCORBATE_AND_ALDARATE_ METABOLISM | 8 | ALDH3A1(1) | 6413 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0.15 | 0.63 | |
145 | HSA00053_ASCORBATE_ AND_ALDARATE_METABOLISM | Genes involved in ascorbate and aldarate metabolism | 9 | ALDH3A1(1) | 6413 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0.15 | 0.63 |
146 | HSA04020_CALCIUM_ SIGNALING_PATHWAY | Genes involved in calcium signaling pathway | 159 | ADCY3(1), ADCY4(1), ADCY8(7), ATP2A3(1), ATP2B1(1), ATP2B2(4), ATP2B4(1), CACNA1A(1), CACNA1D(6), CACNA1F(2), CACNA1G(4), CACNA1H(1), CACNA1I(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), GNA11(1), GNAS(3), ITPR1(2), ITPR3(4), MYLK(4), NOS3(1), PDE1A(1), PDE1B(1), PDGFRB(3), PLCB4(3), PLCD1(1), PLCD4(2), PLCE1(2), PPP3CC(1), PRKCA(2), PTK2B(2), SLC8A2(1), SLC8A3(4) | 1137451 | 77 | 51 | 77 | 25 | 25 | 27 | 16 | 3 | 6 | 0.15 | 0.63 |
147 | HSA04920_ADIPOCYTOKINE_ SIGNALING_PATHWAY | Genes involved in adipocytokine signaling pathway | 71 | ACACB(4), ACSL3(1), ACSL5(1), ADIPOR1(1), CAMKK1(1), CD36(1), CHUK(2), IRS4(7), JAK1(1), JAK2(1), LEPR(1), PRKAG2(1), TNFRSF1B(1) | 360476 | 23 | 21 | 23 | 4 | 6 | 7 | 2 | 4 | 4 | 0.16 | 0.66 |
148 | ACE_INHIBITOR_PATHWAY_ PHARMGKB | 8 | NOS3(1), REN(1) | 24480 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0.16 | 0.66 | |
149 | HSA00670_ONE_CARBON_ POOL_BY_FOLATE | Genes involved in one carbon pool by folate | 16 | ALDH1L1(2), MTHFD1L(1) | 25509 | 3 | 3 | 3 | 4 | 1 | 1 | 0 | 0 | 1 | 0.16 | 0.66 |
150 | ONE_CARBON_POOL_ BY_FOLATE | 15 | ALDH1L1(2), MTHFD1L(1) | 25509 | 3 | 3 | 3 | 4 | 1 | 1 | 0 | 0 | 1 | 0.16 | 0.66 | |
151 | CDC42RACPATHWAY | PI3 kinase stimulates cell migration by activating cdc42, which activates ARP2/3, which in turn promotes formation of new actin fibers. | 14 | WASL(2) | 32512 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0.16 | 0.66 |
152 | NTHIPATHWAY | Hemophilus influenzae infections activate NF-kB via several pathways, inducing the inflammatory response. | 22 | CHUK(2), CREBBP(2), MAP2K6(1) | 102272 | 5 | 5 | 5 | 1 | 0 | 2 | 0 | 0 | 3 | 0.17 | 0.69 |
153 | HSA00640_PROPANOATE_ METABOLISM | Genes involved in propanoate metabolism | 33 | ACACA(2), ACACB(4), ACSS1(1), ALDH3A1(1), EHHADH(1), LDHC(1) | 148171 | 10 | 10 | 10 | 6 | 2 | 2 | 4 | 2 | 0 | 0.17 | 0.70 |
154 | HSA00760_NICOTINATE_ AND_NICOTINAMIDE_ METABOLISM | Genes involved in nicotinate and nicotinamide metabolism | 22 | ENPP3(2), NNMT(1), NNT(1), NT5E(1) | 63101 | 5 | 5 | 5 | 2 | 2 | 0 | 2 | 1 | 0 | 0.18 | 0.72 |
155 | FRUCTOSE_AND_MANNOSE_ METABOLISM | 25 | GCK(2), GMPPA(4), HK1(1), PFKP(1) | 154858 | 8 | 7 | 8 | 3 | 0 | 3 | 2 | 3 | 0 | 0.18 | 0.72 | |
156 | SPPAPATHWAY | Thrombin cleaves protease-activated receptors PAR1 and PAR4 to induce calcium influx and activate platelet aggregation, a process inhibited by aspirin. | 20 | ITGA1(1), PLA2G4A(3), PRKCA(2), PTK2(2) | 79259 | 8 | 6 | 8 | 4 | 3 | 2 | 2 | 0 | 1 | 0.18 | 0.73 |
157 | ERK5PATHWAY | Signaling between a tissue and its innervating axon stimulates retrograde transport via Trk receptors, which activate Erk5, which induces transcription of anti-apoptotic factors. | 17 | CREB1(1), NTRK1(4) | 82432 | 5 | 5 | 4 | 2 | 0 | 2 | 0 | 1 | 2 | 0.19 | 0.73 |
158 | INTRINSICPATHWAY | The intrinsic prothrombin activation pathway is activated by traumatized blood vessels and induces clot formation. | 21 | COL4A1(2), COL4A3(1), COL4A4(5), F5(4) | 132050 | 12 | 10 | 12 | 12 | 4 | 4 | 2 | 0 | 2 | 0.19 | 0.73 |
159 | IL22BPPATHWAY | IL-22 is produced by T cells and induces the acute phase inflammatory response in hepatocytes. | 13 | IL10RA(1), JAK1(1), JAK2(1), STAT1(2), STAT5B(1) | 68698 | 6 | 6 | 6 | 1 | 2 | 2 | 0 | 1 | 1 | 0.19 | 0.73 |
160 | P27PATHWAY | p27 blocks the G1/S transition by inhibiting the checkpoint kinase cdk2/cyclin E and is inhibited by cdk2-mediated ubiquitination. | 12 | SKP2(2) | 23400 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.19 | 0.73 |
161 | SKP2E2FPATHWAY | E2F-1, a transcription factor that promotes the G1/S transition, is repressed by Rb and activated by cdk2/cyclin E. | 9 | SKP2(2) | 23400 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.19 | 0.73 |
162 | ERBB4PATHWAY | ErbB4 (aka HER4) is a receptor tyrosine kinase that binds neuregulins as well as members of the EGF family, which also target EGF receptors. | 6 | ADAM17(2), PRKCA(2) | 34535 | 4 | 4 | 4 | 3 | 2 | 1 | 1 | 0 | 0 | 0.19 | 0.73 |
163 | ST_DIFFERENTIATION_ PATHWAY_IN_PC12_ CELLS | Rat-derived PC12 cells respond to nerve growth factor (NGF) and PACAP to differentiate into neuronal cells. | 41 | CREB1(1), CREBBP(2), MAP1B(4), MAP2K4(1), MAPK8IP1(1), NTRK1(4), OPN1LW(1) | 219156 | 14 | 12 | 13 | 5 | 4 | 5 | 0 | 1 | 4 | 0.19 | 0.73 |
164 | ST_B_CELL_ANTIGEN_ RECEPTOR | B cell receptors bind antigens and promote B cell activation. | 39 | BCR(1), BLNK(1), BTK(4), EPHB2(1), LYN(1), NFAT5(2), SOS1(3) | 209546 | 13 | 13 | 13 | 2 | 1 | 4 | 6 | 0 | 2 | 0.20 | 0.73 |
165 | 41BBPATHWAY | TNF-type receptor 4-1BB is bound by TRAF1 to activate the MAP kinase pathway in activated T cells. | 18 | CHUK(2) | 50546 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.20 | 0.73 |
166 | HSA00534_HEPARAN_ SULFATE_BIOSYNTHESIS | Genes involved in heparan sulfate biosynthesis | 19 | EXT2(1), EXTL1(1), NDST2(2) | 36619 | 4 | 4 | 4 | 1 | 2 | 2 | 0 | 0 | 0 | 0.20 | 0.74 |
167 | TNFR1PATHWAY | Tumor necrosis factor alpha binds to its receptor TNFR1 and induces caspase-dependent apoptosis. | 27 | LMNB1(1), MADD(4), MAP2K4(1), SPTAN1(3) | 257112 | 9 | 9 | 9 | 1 | 1 | 0 | 2 | 3 | 3 | 0.20 | 0.74 |
168 | ST_GA12_PATHWAY | G-alpha-12 promotes cell survival and proliferation, is involved in the stress response, and activates JNK. | 22 | BTK(4), EPHB2(1), F2RL2(3), PTK2(2) | 119864 | 10 | 10 | 10 | 2 | 1 | 4 | 3 | 0 | 2 | 0.20 | 0.74 |
169 | HSA04630_JAK_STAT_ SIGNALING_PATHWAY | Genes involved in Jak-STAT signaling pathway | 152 | CREBBP(2), IFNA16(2), IL10RA(1), IL12RB2(2), IL19(1), IL21R(2), IL28B(1), IL5RA(1), JAK1(1), JAK2(1), LEPR(1), PIAS1(1), PIK3R5(2), SOS1(3), STAT1(2), STAT2(2), STAT5B(1), TPO(6), TSLP(1) | 467142 | 33 | 25 | 33 | 11 | 8 | 12 | 4 | 4 | 5 | 0.20 | 0.74 |
170 | EPHA4PATHWAY | Eph Kinases and ephrins support platelet aggregation | 9 | ITGA1(1), LYN(1) | 24338 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0.21 | 0.75 |
171 | HSA00030_PENTOSE_ PHOSPHATE_PATHWAY | Genes involved in pentose phosphate pathway | 26 | GPI(2), PFKP(1), PGD(1), TKTL1(3) | 113030 | 7 | 7 | 7 | 4 | 0 | 2 | 2 | 2 | 1 | 0.21 | 0.75 |
172 | RASPATHWAY | Ras activation stimulates many signaling cascades, including PI3K/AKT activation to inhibit apoptosis. | 21 | CHUK(2) | 49152 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0.21 | 0.76 |
173 | ST_IL_13_PATHWAY | Like IL-4, IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 7 | JAK1(1), JAK2(1) | 26458 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.21 | 0.76 |
174 | ST_INTERLEUKIN_13_ PATHWAY | IL-13 is produced by Th2 cells on activation of the T cell antigen receptor, and by mast and basophil cells on activation of the IgE receptor. | 7 | JAK1(1), JAK2(1) | 26458 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.21 | 0.76 |
175 | HSA04012_ERBB_SIGNALING_ PATHWAY | Genes involved in ErbB signaling pathway | 82 | ARAF(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), MAP2K4(1), PIK3R5(2), PRKCA(2), PTK2(2), SOS1(3), STAT5B(1) | 273144 | 17 | 14 | 17 | 6 | 8 | 3 | 4 | 0 | 2 | 0.22 | 0.77 |
176 | SIG_IL4RECEPTOR_ IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes | 27 | JAK1(1), SOS1(3) | 58006 | 4 | 4 | 4 | 2 | 1 | 0 | 2 | 1 | 0 | 0.22 | 0.78 |
177 | HSA04512_ECM_RECEPTOR_ INTERACTION | Genes involved in ECM-receptor interaction | 78 | AGRN(1), CD36(1), COL11A2(2), COL4A1(2), COL4A4(5), COL5A3(5), FNDC3A(2), GP1BA(1), GP5(1), HSPG2(5), ITGA1(1), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), ITGB4(1), LAMA5(3), LAMB1(4), LAMB2(8), LAMB3(3), LAMC3(3), TNXB(5) | 971435 | 64 | 40 | 64 | 18 | 13 | 33 | 5 | 7 | 6 | 0.22 | 0.78 |
178 | AKAPCENTROSOMEPATHWAY | Protein Kinase A at the Centrosome | 9 | PRKCE(1) | 9921 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.23 | 0.79 |
179 | APOPTOSIS_KEGG | 48 | CASP10(2), NTRK1(4), PTPN13(3), SFRS2IP(1), TNFRSF1B(1) | 128774 | 11 | 9 | 10 | 3 | 3 | 4 | 1 | 1 | 2 | 0.23 | 0.79 | |
180 | G1PATHWAY | CDK4/6-cyclin D and CDK2-cyclin E phosphorylate Rb, which allows the transcription of genes needed for the G1/S cell cycle transition. | 24 | CDK4(1), CDK6(1), SKP2(2) | 46188 | 4 | 4 | 4 | 0 | 1 | 2 | 0 | 1 | 0 | 0.23 | 0.79 |
181 | TCRPATHWAY | T cell receptors bind to foreign peptides presented by MHC molecules and induce T cell activation. | 42 | LAT(1), MAP2K4(1), NFATC3(2), PPP3CC(1), PRKCA(2), RASA1(1), SOS1(3) | 162663 | 11 | 10 | 11 | 5 | 5 | 0 | 4 | 1 | 1 | 0.24 | 0.80 |
182 | PMLPATHWAY | Ring-shaped PML nuclear bodies regulate transcription and are required co-activators in p53- and DAXX-mediated apoptosis. | 13 | CREBBP(2), PML(1), SP100(2), TNFRSF1B(1) | 75015 | 6 | 6 | 6 | 1 | 1 | 1 | 3 | 0 | 1 | 0.24 | 0.80 |
183 | HSA04650_NATURAL_ KILLER_CELL_MEDIATED_ CYTOTOXICITY | Genes involved in natural killer cell mediated cytotoxicity | 124 | ARAF(1), HCST(1), IFNA16(2), ITGAL(6), LAT(1), NFAT5(2), NFATC3(2), PIK3R5(2), PPP3CC(1), PRKCA(2), PTK2B(2), SOS1(3) | 391281 | 25 | 19 | 25 | 5 | 11 | 6 | 5 | 2 | 1 | 0.24 | 0.81 |
184 | IL4PATHWAY | IL-4 promotes Th2 cell differentiation via a heterodimeric receptor that activates Stat6/JAK and MAP kinase pathways. | 11 | JAK1(1) | 19805 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0.25 | 0.84 |
185 | DNA_POLYMERASE | 6 | POLD1(2) | 35655 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0.26 | 0.85 | |
186 | HSA00361_GAMMA_HEXACHLOROCYCLOHEXANE_ DEGRADATION | Genes involved in gamma-hexachlorocyclohexane degradation | 23 | ACP5(2), ACP6(1), ACPP(1), ALPP(1), CYP3A7(3) | 98456 | 8 | 7 | 8 | 1 | 2 | 5 | 0 | 0 | 1 | 0.26 | 0.86 |
187 | SPRYPATHWAY | Four members of the Sprouty protein family block proliferative EGF signals by binding Grb-2, preventing Ras and MAP kinase activation. | 16 | RASA1(1), SOS1(3) | 56613 | 4 | 4 | 4 | 3 | 1 | 0 | 3 | 0 | 0 | 0.26 | 0.86 |
188 | IL2PATHWAY | IL-2 promotes proliferation via JAK and MAP kinase and has surface receptors on activated B cells, LPS-treated monocytes, and many T cells. | 22 | JAK1(1), SOS1(3), STAT5B(1) | 73125 | 5 | 5 | 5 | 2 | 2 | 0 | 2 | 1 | 0 | 0.26 | 0.86 |
189 | SRCRPTPPATHWAY | Activation of Src by Protein-tyrosine phosphatase alpha | 9 | PRKCA(2) | 25946 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0.27 | 0.86 |
190 | SIG_PIP3_SIGNALING_ IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes | 63 | CREB1(1), F2RL2(3), IFI27(1), IRS4(7), MET(2), NOLC1(1), PARD3(1), PTK2(2), RPS6KA2(1), SOS1(3) | 342970 | 22 | 19 | 22 | 5 | 5 | 6 | 8 | 2 | 1 | 0.27 | 0.86 |
191 | TSP1PATHWAY | Thrombospondin-1 (TSP-1) inhibits angiogenesis by inducing caspase-dependent apoptosis in microvascular endothelial cells. | 7 | CD36(1) | 5236 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.27 | 0.86 |
192 | EXTRINSICPATHWAY | The extrinsic prothrombin activation pathway requires the release of thromboplastin from damaged tissues to activate the blood clotting cascade. | 13 | F5(4) | 36941 | 4 | 4 | 4 | 4 | 1 | 2 | 1 | 0 | 0 | 0.27 | 0.86 |
193 | GLYCEROLIPID_METABOLISM | 44 | ADH1B(4), ADH6(2), ALDH3A1(1), DGAT1(2), PNLIPRP1(3), PNLIPRP2(3) | 214341 | 15 | 13 | 15 | 5 | 4 | 7 | 1 | 0 | 3 | 0.27 | 0.86 | |
194 | TALL1PATHWAY | APRIL and BAFF bind to BCMA and TACI receptors on B cell surfaces, promoting immunoglobulin production and cell proliferation. | 15 | CHUK(2) | 65865 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.27 | 0.87 |
195 | VIPPATHWAY | Apoptosis of activated T cells is inhibited by vasoactive intestinal peptide (VIP) and its relative PACAP. | 27 | CHUK(2), PPP3CC(1) | 67918 | 3 | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 2 | 0.28 | 0.87 |
196 | GAMMA_HEXACHLOROCYCLOHEXANE_ DEGRADATION | 30 | ACP5(2), ACPP(1), ALPP(1), CYP2A13(2), CYP2C19(1), CYP2E1(1), CYP3A7(3) | 168571 | 11 | 10 | 11 | 2 | 2 | 8 | 0 | 0 | 1 | 0.28 | 0.87 | |
197 | PENTOSE_PHOSPHATE_ PATHWAY | 23 | GPI(2), PFKP(1), PGD(1) | 97350 | 4 | 4 | 4 | 4 | 0 | 2 | 0 | 2 | 0 | 0.28 | 0.87 | |
198 | S1PPATHWAY | At low cholesterol concentrations, sterol-regulatory element binding proteins (SREBPs) act as transcription factors to promote cholesterol uptake and biosynthesis. | 7 | LDLR(2) | 16638 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0.28 | 0.88 |
199 | HSA00565_ETHER_LIPID_ METABOLISM | Genes involved in ether lipid metabolism | 30 | AGPS(1), ENPP2(2), PLA2G4A(3) | 61762 | 6 | 5 | 6 | 3 | 1 | 3 | 2 | 0 | 0 | 0.29 | 0.89 |
200 | HSA04662_B_CELL_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in B cell receptor signaling pathway | 62 | BLNK(1), BTK(4), CD22(2), CHUK(2), INPP5D(1), LYN(1), NFAT5(2), NFATC3(2), PIK3R5(2), PPP3CC(1), RASGRP3(1) | 348081 | 19 | 15 | 19 | 5 | 3 | 5 | 5 | 1 | 5 | 0.30 | 0.91 |
201 | HSA00401_NOVOBIOCIN_ BIOSYNTHESIS | Genes involved in novobiocin biosynthesis | 3 | TAT(1) | 9428 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.30 | 0.91 |
202 | RAC1PATHWAY | Rac-1 is a Rho family G protein that stimulates formation of actin-dependent structures such as filopodia and lamellopodia. | 22 | MYLK(4), PPP1R12B(2), TRIO(2), WASF1(2) | 164348 | 10 | 8 | 10 | 4 | 1 | 4 | 1 | 2 | 2 | 0.30 | 0.91 |
203 | FATTY_ACID_BIOSYNTHESIS_ PATH_2 | 9 | EHHADH(1), HADHB(3) | 40057 | 4 | 4 | 4 | 0 | 2 | 1 | 1 | 0 | 0 | 0.30 | 0.91 | |
204 | HSA04620_TOLL_LIKE_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in Toll-like receptor signaling pathway | 100 | CHUK(2), IFNA16(2), MAP2K4(1), MAP2K6(1), PIK3R5(2), STAT1(2), TLR9(3), TOLLIP(1) | 254763 | 14 | 12 | 14 | 4 | 4 | 4 | 1 | 1 | 4 | 0.30 | 0.92 |
205 | HSP27PATHWAY | Hsp27 oligomers have molecular chaperone activity and protect heat-stressed cells against apoptosis. | 15 | MAPKAPK2(1) | 9810 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.31 | 0.92 |
206 | HSA00650_BUTANOATE_ METABOLISM | Genes involved in butanoate metabolism | 45 | AACS(1), ACSM1(1), ALDH3A1(1), EHHADH(1), HSD17B4(2) | 82789 | 6 | 6 | 6 | 3 | 2 | 1 | 2 | 1 | 0 | 0.31 | 0.92 |
207 | MALATEXPATHWAY | The tricarboxylate transfer pathway shuttles acetyl groups of acetyl-CoA between mitochondria and the cytoplasm. | 8 | ACLY(2), PC(1) | 75347 | 3 | 3 | 2 | 1 | 0 | 0 | 3 | 0 | 0 | 0.31 | 0.92 |
208 | SIG_INSULIN_RECEPTOR_ PATHWAY_IN_CARDIAC_ MYOCYTES | Genes related to the insulin receptor pathway | 49 | BRD4(3), F2RL2(3), IRS4(7), PARD3(1), RPS6KA2(1), SORBS1(3), SOS1(3) | 316834 | 21 | 18 | 21 | 5 | 5 | 5 | 7 | 2 | 2 | 0.31 | 0.92 |
209 | BIOGENIC_AMINE_SYNTHESIS | 15 | DDC(2) | 27228 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.31 | 0.92 | |
210 | P53HYPOXIAPATHWAY | Hypoxia induces p53 accumulation and consequent apoptosis with p53-mediated cell cycle arrest, which is present under conditions of DNA damage. | 18 | ABCB1(3) | 38410 | 3 | 3 | 3 | 2 | 1 | 0 | 1 | 0 | 1 | 0.31 | 0.92 |
211 | KERATINOCYTEPATHWAY | Keratinocyte differentiation, which models the differentiation of epidermal cells, requires the four main MAP kinase pathways. | 42 | CHUK(2), MAP2K4(1), MAP2K6(1), PRKCA(2), PRKCE(1), TNFRSF1B(1) | 162737 | 8 | 8 | 8 | 2 | 3 | 1 | 1 | 0 | 3 | 0.32 | 0.93 |
212 | CCR3PATHWAY | CCR3 is a G-protein coupled receptor that recruits eosinophils to inflammation sites via chemokine ligands. | 20 | GNAS(3), PPP1R12B(2), PRKCA(2), PTK2(2) | 116667 | 9 | 9 | 9 | 5 | 3 | 2 | 3 | 0 | 1 | 0.32 | 0.93 |
213 | LEPTINPATHWAY | Leptin is a peptide secreted by adipose tissue that, in skeletal muscle, promotes fatty acid oxidation, decreases cells' lipid content, and promotes insulin sensitivity. | 10 | ACACA(2), LEPR(1), PRKAG2(1) | 51357 | 4 | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 0.32 | 0.93 |
214 | CD40PATHWAY | The CD40 receptor is a TNF-type receptor that regulates immunoglobulin expression in B cells and moderates T cell activation via T-cell expression of its ligand. | 13 | CHUK(2) | 79300 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.33 | 0.95 |
215 | BUTANOATE_METABOLISM | 27 | AACS(1), ALDH3A1(1), EHHADH(1) | 39933 | 3 | 3 | 3 | 2 | 0 | 1 | 2 | 0 | 0 | 0.33 | 0.95 | |
216 | MEF2DPATHWAY | Mef2 transcription factors promote calcium-induced apoptosis in T cells and are regulated by MAP kinases and histone deacetylases. | 18 | CABIN1(2), HDAC2(1), PPP3CC(1), PRKCA(2) | 108045 | 6 | 5 | 6 | 1 | 4 | 0 | 1 | 0 | 1 | 0.34 | 0.96 |
217 | HSA00512_O_GLYCAN_ BIOSYNTHESIS | Genes involved in O-glycan biosynthesis | 29 | GALNT7(1), GALNT8(1), GALNTL2(2), OGT(2) | 131745 | 6 | 6 | 6 | 4 | 1 | 2 | 1 | 2 | 0 | 0.34 | 0.98 |
218 | HSA04740_OLFACTORY_ TRANSDUCTION | Genes involved in olfactory transduction | 30 | ADCY3(1), ADRBK2(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CLCA4(3), CNGB1(1) | 128815 | 11 | 9 | 11 | 2 | 4 | 4 | 2 | 0 | 1 | 0.35 | 1.00 |
219 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. | 15 | CASP10(2) | 47342 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 0.35 | 1.00 |
220 | HSA00051_FRUCTOSE_ AND_MANNOSE_METABOLISM | Genes involved in fructose and mannose metabolism | 40 | GMPPA(4), HK1(1), PFKP(1) | 132821 | 6 | 6 | 6 | 2 | 0 | 2 | 2 | 2 | 0 | 0.36 | 1.00 |
221 | HSA00130_UBIQUINONE_ BIOSYNTHESIS | Genes involved in ubiquinone biosynthesis | 8 | COQ3(1) | 18598 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.36 | 1.00 |
222 | HSA04150_MTOR_SIGNALING_ PATHWAY | Genes involved in mTOR signaling pathway | 43 | EIF4B(2), PIK3R5(2), RICTOR(3), RPS6KA2(1), ULK2(2) | 114209 | 10 | 8 | 10 | 2 | 3 | 4 | 2 | 0 | 1 | 0.36 | 1.00 |
223 | PTENPATHWAY | PTEN suppresses AKT-induced cell proliferation and antagonizes the action of PI3K. | 16 | PTK2(2), SOS1(3) | 69411 | 5 | 5 | 5 | 2 | 1 | 1 | 3 | 0 | 0 | 0.36 | 1.00 |
224 | HSA05130_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EHEC | Genes involved in pathogenic Escherichia coli infection - EHEC | 51 | CDH1(1), PRKCA(2), TUBA4A(1), TUBB4(1), WASL(2) | 161468 | 7 | 7 | 7 | 3 | 5 | 0 | 0 | 1 | 1 | 0.37 | 1.00 |
225 | HSA05131_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EPEC | Genes involved in pathogenic Escherichia coli infection - EPEC | 51 | CDH1(1), PRKCA(2), TUBA4A(1), TUBB4(1), WASL(2) | 161468 | 7 | 7 | 7 | 3 | 5 | 0 | 0 | 1 | 1 | 0.37 | 1.00 |
226 | APOPTOSIS | 68 | BIRC5(1), CASP10(2), CHUK(2), MAP2K4(1), TNFRSF1B(1) | 184614 | 7 | 6 | 7 | 0 | 1 | 0 | 2 | 1 | 3 | 0.37 | 1.00 | |
227 | STRESSPATHWAY | Tumor necrosis factor receptor TNFR1 promotes apoptosis and activates the pro-inflammatory NF-kB, while TNFR2 activates stress-activated protein kinases (SAPKs). | 25 | CHUK(2), MAP2K4(1), MAP2K6(1) | 163853 | 4 | 4 | 4 | 0 | 0 | 1 | 0 | 0 | 3 | 0.37 | 1.00 |
228 | HSA04010_MAPK_SIGNALING_ PATHWAY | Genes involved in MAPK signaling pathway | 243 | ACVR1C(1), CACNA1A(1), CACNA1D(6), CACNA1F(2), CACNA1G(4), CACNA1H(1), CACNA1I(1), CACNB2(1), CHUK(2), DDIT3(1), FLNA(1), FLNB(1), MAP2K4(1), MAP2K6(1), MAP3K12(1), MAP4K3(1), MAPK8IP1(1), MAPKAPK2(1), NF1(7), NTRK1(4), PDGFRB(3), PLA2G4A(3), PPP3CC(1), PRKCA(2), RASA1(1), RASA2(2), RASGRF2(4), RASGRP3(1), RPS6KA2(1), RPS6KA4(1), SOS1(3), TAOK2(6), ZAK(2) | 1340730 | 69 | 45 | 67 | 22 | 17 | 20 | 15 | 4 | 13 | 0.38 | 1.00 |
229 | CIRCADIANPATHWAY | A heterodimer composed of Bmal1 and Clock acts as a transcription factor for proteins that regulate circadian rhythms, such as Per and Cry. | 6 | PER1(1) | 16534 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.38 | 1.00 |
230 | HSA04514_CELL_ADHESION_ MOLECULES | Genes involved in cell adhesion molecules (CAMs) | 127 | CD22(2), CDH1(1), CDH5(1), CNTN1(6), ITGA8(6), ITGAL(6), ITGAM(3), MAG(2), NLGN2(1), NRCAM(6), PTPRC(6), PTPRF(2), SELE(3) | 693595 | 45 | 32 | 45 | 19 | 13 | 17 | 5 | 4 | 6 | 0.38 | 1.00 |
231 | GLEEVECPATHWAY | The drug Gleevec specifically targets the abnormal bcr-abl protein, an apoptosis inhibitor present in chronic myeloid leukemia. | 22 | BCR(1), JAK2(1), MAP2K4(1), SOS1(3), STAT1(2), STAT5B(1) | 103087 | 9 | 8 | 9 | 3 | 3 | 3 | 2 | 0 | 1 | 0.38 | 1.00 |
232 | ETSPATHWAY | The Ets transcription factors are activated by Ras and promote macrophage differentiation. | 18 | CSF1R(2), DDX20(1), HDAC2(1), HDAC5(1), NCOR2(3), RBL1(1) | 137254 | 9 | 9 | 9 | 5 | 4 | 1 | 2 | 1 | 1 | 0.38 | 1.00 |
233 | HSA04660_T_CELL_ RECEPTOR_SIGNALING_ PATHWAY | Genes involved in T cell receptor signaling pathway | 92 | CDK4(1), CHUK(2), GRAP2(1), LAT(1), NFAT5(2), NFATC3(2), PIK3R5(2), PPP3CC(1), PTPRC(6), SOS1(3) | 285490 | 21 | 18 | 21 | 5 | 6 | 6 | 5 | 1 | 3 | 0.38 | 1.00 |
234 | TNFR2PATHWAY | Tumor necrosis factor beta, produced by activated lymphocytes, binds to its receptor TNFR2 to induce activation in immune cells and apoptosis in many other cells. | 18 | CHUK(2), TNFRSF1B(1) | 89140 | 3 | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 2 | 0.39 | 1.00 |
235 | HSA00770_PANTOTHENATE_ AND_COA_BIOSYNTHESIS | Genes involved in pantothenate and CoA biosynthesis | 16 | BCAT2(2), DPYS(3), ENPP3(2), PANK3(1), PANK4(1) | 117442 | 9 | 9 | 9 | 2 | 3 | 4 | 1 | 1 | 0 | 0.39 | 1.00 |
236 | ACETAMINOPHENPATHWAY | Acetaminophen selectively inhibits Cox-3, which is localized to the brain, and yields the toxic metabolite NAPQI when processed by CAR in the liver. | 5 | CYP2E1(1) | 8398 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0.39 | 1.00 |
237 | ST_T_CELL_SIGNAL_ TRANSDUCTION | On activation of the T cell receptor, phospholipase C is activated to produce second messengers DAG and PIP3, both required for T cell activation. | 44 | EPHB2(1), GRAP2(1), LAT(1), NFAT5(2), PTPRC(6), RASGRP3(1), SOS1(3) | 204913 | 15 | 14 | 15 | 4 | 5 | 5 | 4 | 0 | 1 | 0.39 | 1.00 |
238 | CHOLESTEROL_BIOSYNTHESIS | 15 | HMGCR(1) | 16516 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.40 | 1.00 | |
239 | PLCEPATHWAY | Gs-coupled receptors activate adenylyl cyclase, which activates Epac1, leading to the stimulation of PLC and subsequent DAG and IP3 production. | 12 | GNAS(3), PLCE1(2) | 74819 | 5 | 5 | 5 | 3 | 2 | 0 | 2 | 0 | 1 | 0.40 | 1.00 |
240 | NOTCHPATHWAY | Proteolysis and Signaling Pathway of Notch | 5 | ADAM17(2), NOTCH1(2) | 59457 | 4 | 4 | 4 | 2 | 1 | 1 | 2 | 0 | 0 | 0.41 | 1.00 |
241 | PPARGPATHWAY | PPAR-gamma is a nuclear hormone receptor that is activated by fatty acids and regulates transcription through co-activations like Src-1 and Tif2. | 7 | CREBBP(2) | 33527 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0.41 | 1.00 |
242 | HSA00561_GLYCEROLIPID_ METABOLISM | Genes involved in glycerolipid metabolism | 54 | ADH1B(4), ADH6(2), ALDH3A1(1), DGAT1(2), GPAM(1), PNLIPRP1(3), PNLIPRP2(3) | 243850 | 16 | 14 | 16 | 5 | 4 | 7 | 2 | 0 | 3 | 0.42 | 1.00 |
243 | VALINE_LEUCINE_AND_ ISOLEUCINE_DEGRADATION | 36 | ALDH3A1(1), EHHADH(1), HADHB(3), MCCC2(2) | 81030 | 7 | 7 | 7 | 2 | 2 | 3 | 2 | 0 | 0 | 0.42 | 1.00 | |
244 | ST_G_ALPHA_S_PATHWAY | The G-alpha-s protein activates adenylyl cyclases, which catalyze cAMP formation. | 11 | BFAR(1), CREB1(1) | 41936 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.42 | 1.00 |
245 | BIOSYNTHESIS_OF_ STEROIDS | 14 | HMGCR(1) | 17596 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.42 | 1.00 | |
246 | CARBON_FIXATION | 21 | PGK1(2) | 40574 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0.42 | 1.00 | |
247 | PROPANOATE_METABOLISM | 31 | ACACA(2), ALDH3A1(1), EHHADH(1), LDHC(1) | 114091 | 5 | 5 | 5 | 5 | 0 | 1 | 3 | 1 | 0 | 0.43 | 1.00 | |
248 | HSA05110_CHOLERA_ INFECTION | Genes involved in cholera - infection | 41 | ACTG2(2), ADCY3(1), ARF5(1), ATP6V1H(1), GNAS(3), PRKCA(2), SEC61A1(1) | 159080 | 11 | 11 | 11 | 3 | 4 | 2 | 3 | 0 | 2 | 0.43 | 1.00 |
249 | CASPASEPATHWAY | Caspases are cysteine proteases active in apoptosis; caspase-8 and 9 cleave and activate other caspases, while 3, 6, and 7 cleave cellular targets. | 21 | CASP10(2), LMNB1(1) | 84049 | 3 | 2 | 3 | 0 | 0 | 0 | 1 | 1 | 1 | 0.44 | 1.00 |
250 | HSA00902_MONOTERPENOID_ BIOSYNTHESIS | Genes involved in monoterpenoid biosynthesis | 2 | CYP2C19(1) | 9840 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.44 | 1.00 |
251 | PITX2PATHWAY | The bicoid-related transcription factor Pitx2 is activated by Wnt binding to the Frizzled receptor and induces tissue-specific cell proliferation. | 14 | APC(4), AXIN1(1), CREBBP(2), DVL1(1) | 116122 | 8 | 8 | 8 | 2 | 1 | 4 | 1 | 1 | 1 | 0.44 | 1.00 |
252 | DNA_REPLICATION_ REACTOME | 42 | MCM2(1), ORC2L(1), ORC3L(2), POLA2(1), POLD1(2) | 109017 | 7 | 6 | 7 | 0 | 1 | 2 | 3 | 0 | 1 | 0.45 | 1.00 | |
253 | HSA04060_CYTOKINE_ CYTOKINE_RECEPTOR_ INTERACTION | Genes involved in cytokine-cytokine receptor interaction | 250 | CSF1R(2), CXCR3(1), IFNA16(2), IL10RA(1), IL12RB2(2), IL18RAP(2), IL19(1), IL21R(2), IL28B(1), IL5RA(1), INHBC(1), LEPR(1), LTB(1), MET(2), PDGFRB(3), PLEKHO2(1), TNFRSF1B(1), TPO(6), TSLP(1), XCL1(1) | 642627 | 33 | 28 | 33 | 16 | 7 | 10 | 6 | 5 | 5 | 0.46 | 1.00 |
254 | NGFPATHWAY | Nerve growth factor (NGF) stimulates neural survival and proliferation via the TrkA and p75 receptors, which induce DAG and IP3 production and activate Ras. | 18 | SOS1(3) | 49000 | 3 | 3 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0.46 | 1.00 |
255 | ST_FAS_SIGNALING_ PATHWAY | The Fas receptor induces apoptosis and NF-kB activation when bound to Fas ligand. | 58 | BFAR(1), BTK(4), CAD(3), CASP10(2), EPHB2(1), FAIM2(1), MAP2K4(1), MAPK8IP1(1), MET(2), NFAT5(2), PTPN13(3), TPX2(1) | 345891 | 22 | 21 | 22 | 5 | 5 | 6 | 7 | 1 | 3 | 0.47 | 1.00 |
256 | SA_B_CELL_RECEPTOR_ COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. | 24 | BCR(1), BLNK(1), LYN(1), SOS1(3) | 130011 | 6 | 6 | 6 | 4 | 1 | 1 | 4 | 0 | 0 | 0.47 | 1.00 |
257 | CACAMPATHWAY | Calcium functions as a second messenger activating the calcium/calmodulin-dependent kinases, which phosphorylate targets such as CREB. | 14 | CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), CAMKK1(1), CREB1(1) | 134245 | 10 | 9 | 10 | 1 | 3 | 4 | 1 | 1 | 1 | 0.47 | 1.00 |
258 | PS1PATHWAY | Presenilin is required for gamma-secretase activity to activate Notch signaling; presenilin also inhibits beta-catenin in the Wnt/Frizzled pathway. | 12 | ADAM17(2), APC(4), AXIN1(1), DVL1(1), NOTCH1(2) | 142052 | 10 | 9 | 10 | 3 | 2 | 4 | 3 | 1 | 0 | 0.47 | 1.00 |
259 | IGF1RPATHWAY | Insulin-like growth factor receptor IGF-1R promotes cell growth and inhibits apoptosis on binding of ligands IGF-1 and 2 via Ras activation and the AKT pathway. | 15 | SOS1(3) | 51872 | 3 | 3 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0.48 | 1.00 |
260 | GPCRDB_CLASS_B_SECRETIN_ LIKE | 17 | EMR2(1), GPR64(2) | 46859 | 3 | 3 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0.48 | 1.00 | |
261 | WNT_SIGNALING | Wnt signaling genes | 59 | APC(4), AXIN1(1), DVL1(1), DVL3(3), FZD2(1), LDLR(2), PPP2R5C(1), PRKCA(2), PRKCE(1), WNT7A(3) | 253100 | 19 | 16 | 19 | 3 | 4 | 9 | 3 | 1 | 2 | 0.48 | 1.00 |
262 | MITOCHONDRIAL_FATTY_ ACID_BETAOXIDATION | 15 | ACSL3(1), EHHADH(1) | 38659 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.49 | 1.00 | |
263 | SHHPATHWAY | Sonic hedgehog (Shh) signaling in the developing CNS induces neuronal proliferation via interaction with the patched (Ptc-1) and smoothened receptors. | 14 | DYRK1A(1) | 32448 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.49 | 1.00 |
264 | HSA04910_INSULIN_ SIGNALING_PATHWAY | Genes involved in insulin signaling pathway | 129 | ACACA(2), ACACB(4), ARAF(1), GCK(2), GYS2(2), INPP5D(1), INSR(1), IRS4(7), LIPE(1), PFKP(1), PIK3R5(2), PRKAG2(1), PTPRF(2), SORBS1(3), SOS1(3) | 727514 | 33 | 26 | 33 | 14 | 8 | 10 | 8 | 6 | 1 | 0.49 | 1.00 |
265 | FOSBPATHWAY | FOSB gene expression and drug abuse | 5 | FOSB(1) | 23067 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.49 | 1.00 |
266 | EDG1PATHWAY | The lipid S1P is an EDG1 ligand promoting chemotaxis via Rac1 and cell survival and proliferation via ERK activation. | 21 | PRKCA(2), PTK2(2) | 55934 | 4 | 4 | 4 | 2 | 2 | 1 | 1 | 0 | 0 | 0.49 | 1.00 |
267 | P38MAPKPATHWAY | The Rho family GTPases activate the p38 MAPKs under environmental stress or in the presence of pro-inflammatory cytokines. | 39 | CREB1(1), DDIT3(1), MAP2K4(1), MAP2K6(1), MAPKAPK2(1), PLA2G4A(3), STAT1(2) | 149462 | 10 | 9 | 10 | 2 | 4 | 3 | 1 | 1 | 1 | 0.50 | 1.00 |
268 | DEATHPATHWAY | Death receptors such as Fas and DR3, 4, and 5 transduce pro-apoptotic signaling by oligomerizing to activate the caspase cascade. | 32 | CASP10(2), CHUK(2), SPTAN1(3) | 176260 | 7 | 6 | 7 | 1 | 1 | 0 | 3 | 1 | 2 | 0.50 | 1.00 |
269 | HSA04080_NEUROACTIVE_ LIGAND_RECEPTOR_ INTERACTION | Genes involved in neuroactive ligand-receptor interaction | 234 | AVPR2(1), CTSG(1), F2RL2(3), GABBR2(4), GABRA3(2), GABRG3(2), GABRP(1), GABRR1(2), GPR156(3), GRIA1(3), GRIK5(1), GRM2(2), LEPR(1), LTB4R(1), NPY1R(1), NTSR2(1), PARD3(1), PRSS1(2), PTH2R(4), RXFP1(3), THRB(1), TRPV1(1) | 659435 | 41 | 29 | 41 | 18 | 9 | 19 | 10 | 3 | 0 | 0.50 | 1.00 |
270 | HSA00624_1_AND_2_ METHYLNAPHTHALENE_ DEGRADATION | Genes involved in 1- and 2-methylnaphthalene degradation | 22 | ADH1B(4), ADH6(2) | 90096 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 0 | 1 | 0.51 | 1.00 |
271 | TGFBPATHWAY | The TGF-beta receptor responds to ligand binding by activating the SMAD family of transcriptional regulations, commonly blocking cell growth. | 13 | APC(4), CDH1(1), CREBBP(2) | 111881 | 7 | 7 | 7 | 2 | 1 | 3 | 1 | 1 | 1 | 0.51 | 1.00 |
272 | GLUCOCORTICOID_MINERALOCORTICOID_ METABOLISM | 8 | CYP11B2(2) | 23466 | 2 | 2 | 2 | 4 | 0 | 2 | 0 | 0 | 0 | 0.51 | 1.00 | |
273 | GLYCINE_SERINE_AND_ THREONINE_METABOLISM | 36 | AOC2(1), GARS(1), GCAT(2), GLDC(4), PSPH(1), SARDH(1) | 154033 | 10 | 8 | 10 | 2 | 3 | 4 | 1 | 0 | 2 | 0.52 | 1.00 | |
274 | HSA00232_CAFFEINE_ METABOLISM | Genes involved in caffeine metabolism | 7 | CYP2A13(2) | 26951 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0.53 | 1.00 |
275 | AT1RPATHWAY | Binding of angiotensin II to AT1-R activates Ca2+ signaling and the JNK pathway. | 32 | MAP2K4(1), PRKCA(2), PTK2(2), PTK2B(2), SOS1(3) | 131232 | 10 | 10 | 10 | 3 | 3 | 3 | 3 | 0 | 1 | 0.53 | 1.00 |
276 | CDMACPATHWAY | Cadmium 2+ promotes cell proliferation in cultured macrophages by entering the cell via calcium channels and activating the MAP kinase pathway. | 14 | PRKCA(2) | 45537 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0.53 | 1.00 |
277 | G_PROTEIN_SIGNALING | 89 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), AKAP11(2), GNA11(1), ITPR1(2), PDE1A(1), PDE1B(1), PDE4C(2), PDE7B(1), PDE8A(1), PPP3CC(1), PRKCA(2), PRKCE(1), PRKD3(1) | 447621 | 29 | 21 | 29 | 10 | 9 | 10 | 7 | 1 | 2 | 0.53 | 1.00 | |
278 | ALKPATHWAY | Activin receptor-like kinase 3 (ALK3) is required during gestation for cardiac muscle development. | 32 | APC(4), AXIN1(1), DVL1(1) | 89675 | 6 | 6 | 6 | 1 | 1 | 3 | 1 | 1 | 0 | 0.53 | 1.00 |
279 | FOLATE_BIOSYNTHESIS | 9 | ALPP(1), GGH(2) | 35160 | 3 | 2 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0.53 | 1.00 | |
280 | NUCLEOTIDE_METABOLISM | 14 | POLD1(2), RRM1(1) | 84238 | 3 | 3 | 3 | 0 | 0 | 0 | 2 | 0 | 1 | 0.54 | 1.00 | |
281 | CIRCADIAN_EXERCISE | 40 | PER1(1), ZFR(2) | 72558 | 3 | 3 | 3 | 1 | 0 | 1 | 1 | 1 | 0 | 0.54 | 1.00 | |
282 | STAT3PATHWAY | The STAT transcription factors are phosphorylated and activated by JAK kinases in response to cytokine signaling. | 7 | JAK1(1), JAK2(1) | 52059 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 0.54 | 1.00 |
283 | SA_REG_CASCADE_OF_ CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. | 13 | CDK4(1) | 13281 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.55 | 1.00 |
284 | EGFR_SMRTEPATHWAY | EGF receptor activation inhibits SMRT, a transcriptional co-repressor that interacts with transcription factor complexes and gene silencers. | 9 | NCOR2(3), THRB(1) | 89545 | 4 | 4 | 4 | 1 | 2 | 1 | 0 | 1 | 0 | 0.55 | 1.00 |
285 | FEEDERPATHWAY | Sugars such as mannose, galactose, and fructose are enzymatically converted to glucose via feeder pathways that lead to glycolysis. | 9 | HK1(1), TREH(1) | 51075 | 2 | 1 | 2 | 2 | 0 | 1 | 0 | 1 | 0 | 0.55 | 1.00 |
286 | MTORPATHWAY | Mammalian target of rapamycin (mTOR) senses mitogenic factors and nutrients, including ATP, and induces cell proliferation. | 21 | EIF4B(2), EIF4G3(4) | 81509 | 6 | 5 | 6 | 0 | 2 | 2 | 2 | 0 | 0 | 0.55 | 1.00 |
287 | HSA04310_WNT_SIGNALING_ PATHWAY | Genes involved in Wnt signaling pathway | 145 | APC(4), APC2(1), AXIN1(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CHD8(3), CREBBP(2), CTBP2(1), DVL1(1), DVL3(3), FZD2(1), LRP5(2), LRP6(1), NFAT5(2), NFATC3(2), PLCB4(3), PPP2R2A(2), PPP3CC(1), PRKCA(2), SENP2(1), WNT7A(3) | 712824 | 41 | 30 | 41 | 5 | 10 | 14 | 7 | 3 | 7 | 0.56 | 1.00 |
288 | HSA04340_HEDGEHOG_ SIGNALING_PATHWAY | Genes involved in Hedgehog signaling pathway | 55 | CSNK1G1(1), LRP2(3), STK36(2), WNT7A(3) | 161047 | 9 | 8 | 9 | 1 | 1 | 6 | 1 | 1 | 0 | 0.56 | 1.00 |
289 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. | 16 | PTK2B(2), SOS1(3) | 68931 | 5 | 5 | 5 | 2 | 1 | 2 | 2 | 0 | 0 | 0.56 | 1.00 |
290 | HSA04210_APOPTOSIS | Genes involved in apoptosis | 81 | CASP10(2), CHUK(2), IRAK2(2), IRAK3(2), NTRK1(4), PIK3R5(2), PPP3CC(1) | 340002 | 15 | 13 | 14 | 3 | 2 | 7 | 1 | 1 | 4 | 0.56 | 1.00 |
291 | SELENOAMINO_ACID_ METABOLISM | 12 | MARS(1), PAPSS2(1) | 26075 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0.56 | 1.00 | |
292 | HSA00020_CITRATE_ CYCLE | Genes involved in citrate cycle (TCA cycle) | 26 | ACLY(2), IDH3B(1), OGDH(1), PC(1) | 172383 | 5 | 5 | 4 | 1 | 0 | 1 | 4 | 0 | 0 | 0.57 | 1.00 |
293 | IGF1PATHWAY | Growth factor IGF-1 stimulates growth and inhibits apoptosis by activating the MAP kinase pathway in a variety of cell types. | 20 | RASA1(1), SOS1(3) | 97829 | 4 | 4 | 4 | 3 | 1 | 0 | 3 | 0 | 0 | 0.57 | 1.00 |
294 | HISTONE_METHYLTRANSFERASE | Genes with HMT activity | 57 | ASH1L(3), DOT1L(1), MLL(2), MLL4(2), OGT(2), SETD1A(1), SETD2(4), WHSC1L1(4) | 477256 | 19 | 17 | 19 | 7 | 5 | 4 | 3 | 4 | 3 | 0.57 | 1.00 |
295 | NO1PATHWAY | Shear stress in endothelial cells increases cytoplasmic calcium, which activates nitric oxide synthase III to release NO, which in turn regulates cardiac contractions. | 26 | CHRNA1(3), NOS3(1), SLC7A1(1) | 171676 | 5 | 4 | 5 | 0 | 2 | 0 | 0 | 2 | 1 | 0.57 | 1.00 |
296 | HSA00500_STARCH_ AND_SUCROSE_METABOLISM | Genes involved in starch and sucrose metabolism | 82 | AGL(3), DDX4(1), DDX54(1), ENPP3(2), GCK(2), GPI(2), GYS2(2), HK1(1), MGAM(6), RUVBL2(1), SETX(1), SKIV2L2(2), TREH(1), UGT2B15(1) | 524807 | 26 | 22 | 26 | 7 | 7 | 12 | 1 | 4 | 2 | 0.57 | 1.00 |
297 | IL3PATHWAY | IL-3 promotes proliferation and differentiation of hematopoietic cells via a heterodimeric receptor that activates the Stat5 and MAP kinase pathways. | 15 | JAK2(1), SOS1(3), STAT5B(1) | 89654 | 5 | 5 | 5 | 2 | 2 | 1 | 2 | 0 | 0 | 0.58 | 1.00 |
298 | LIMONENE_AND_PINENE_ DEGRADATION | 12 | ALDH3A1(1), EHHADH(1) | 33093 | 2 | 2 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 0.58 | 1.00 | |
299 | CYSTEINE_METABOLISM | 8 | LDHC(1) | 25198 | 1 | 1 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0.58 | 1.00 | |
300 | HSA00272_CYSTEINE_ METABOLISM | Genes involved in cysteine metabolism | 17 | LDHC(1) | 25198 | 1 | 1 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0.58 | 1.00 |
301 | HSA04510_FOCAL_ADHESION | Genes involved in focal adhesion | 181 | ACTN3(2), COL11A2(2), COL4A1(2), COL4A4(5), COL5A3(5), DOCK1(4), FLNA(1), FLNB(1), GRLF1(3), ITGA1(1), ITGA2(3), ITGA5(1), ITGA7(1), ITGA8(6), ITGB4(1), LAMA5(3), LAMB1(4), LAMB2(8), LAMB3(3), LAMC3(3), MET(2), MYL7(1), MYLK(4), PDGFRB(3), PIK3R5(2), PRKCA(2), PTK2(2), SOS1(3), TLN1(3), TLN2(3), TNXB(5) | 1496465 | 89 | 51 | 89 | 27 | 25 | 38 | 11 | 6 | 9 | 0.58 | 1.00 |
302 | AMINOACYL_TRNA_BIOSYNTHESIS | 21 | GARS(1), HARS(1), LARS(4), LARS2(1), MARS(1), WARS(1) | 154860 | 9 | 8 | 9 | 4 | 1 | 5 | 2 | 1 | 0 | 0.58 | 1.00 | |
303 | NFKBPATHWAY | Inactive nuclear factor kB (NF-kB) is inhibited by the IkB family in the cytoplasm; active NF-kB is localized in the nucleus and regulates transcription of a variety of genes. | 22 | CHUK(2), TNFRSF1B(1) | 132751 | 3 | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 2 | 0.59 | 1.00 |
304 | HSA00310_LYSINE_ DEGRADATION | Genes involved in lysine degradation | 47 | ALDH3A1(1), DOT1L(1), EHHADH(1), GCDH(1), HSD17B4(2), OGDH(1), SETD1A(1) | 200587 | 8 | 8 | 8 | 2 | 3 | 2 | 1 | 2 | 0 | 0.59 | 1.00 |
305 | PYK2PATHWAY | Pyk2 and Rac1 stimulate the JNK cascade and activate MKK3, which activates p38. | 28 | MAP2K4(1), PRKCA(2), PTK2B(2), SOS1(3) | 110232 | 8 | 8 | 8 | 3 | 3 | 2 | 2 | 0 | 1 | 0.59 | 1.00 |
306 | HSA03060_PROTEIN_ EXPORT | Genes involved in protein export | 8 | OXA1L(1) | 15240 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.59 | 1.00 |
307 | HSA00100_BIOSYNTHESIS_ OF_STEROIDS | Genes involved in biosynthesis of steroids | 24 | HMGCR(1) | 26836 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.59 | 1.00 |
308 | HSA01031_GLYCAN_ STRUCTURES_BIOSYNTHESIS_ 2 | Genes involved in glycan structures - biosynthesis 2 | 60 | B4GALT3(1), PIGG(1), PIGO(2) | 118150 | 4 | 4 | 4 | 0 | 0 | 1 | 3 | 0 | 0 | 0.59 | 1.00 |
309 | IL6PATHWAY | IL-6 binding to its receptor activates JAK kinases and a variety of transcription factors, with effects in neuronal differentiation, bone loss, and inflammation. | 21 | JAK1(1), JAK2(1), SOS1(3) | 107315 | 5 | 5 | 5 | 2 | 1 | 1 | 2 | 1 | 0 | 0.60 | 1.00 |
310 | GLUTATHIONE_METABOLISM | 31 | PGD(1) | 74845 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0.60 | 1.00 | |
311 | FASPATHWAY | Binding of the Fas ligand to the Fas receptor induces caspase activation and consequent apoptosis in the Fas-expressing cell. | 26 | CASP10(2), LMNB1(1), MAP2K4(1), PTPN13(3), SPTAN1(3) | 193307 | 10 | 9 | 10 | 2 | 3 | 1 | 3 | 1 | 2 | 0.60 | 1.00 |
312 | ST_ERK1_ERK2_MAPK_ PATHWAY | The Erk1 and Erk2 MAP kinase pathways are regulated by Raf, Mos, and Tpl-2. | 28 | CREB1(1), RPS6KA2(1), SOS1(3) | 107884 | 5 | 5 | 5 | 2 | 1 | 1 | 2 | 1 | 0 | 0.60 | 1.00 |
313 | GPCRDB_CLASS_A_RHODOPSIN_ LIKE | 164 | AVPR2(1), CXCR3(1), F2RL2(3), LTB4R(1), NPY1R(1), NTSR2(1), RGR(1), RHO(1) | 310776 | 10 | 9 | 10 | 1 | 3 | 2 | 2 | 3 | 0 | 0.61 | 1.00 | |
314 | HSA04120_UBIQUITIN_ MEDIATED_PROTEOLYSIS | Genes involved in ubiquitin mediated proteolysis | 39 | SKP2(2), SMURF1(1), SMURF2(2) | 100818 | 5 | 5 | 5 | 0 | 2 | 1 | 1 | 1 | 0 | 0.61 | 1.00 |
315 | HSA04520_ADHERENS_ JUNCTION | Genes involved in adherens junction | 72 | ACTN3(2), ACVR1C(1), CDH1(1), CREBBP(2), CTNND1(3), INSR(1), MET(2), PARD3(1), PTPRF(2), PTPRJ(2), SORBS1(3), WASF1(2), WASF3(1), WASL(2), YES1(3) | 625555 | 28 | 25 | 28 | 7 | 8 | 5 | 6 | 4 | 5 | 0.61 | 1.00 |
316 | HSA04140_REGULATION_ OF_AUTOPHAGY | Genes involved in regulation of autophagy | 29 | IFNA16(2), ULK2(2) | 68125 | 4 | 4 | 4 | 0 | 2 | 2 | 0 | 0 | 0 | 0.61 | 1.00 |
317 | HIVNEFPATHWAY | HIV-infected CD4 helper T cells may express Fas ligand, which binds to the Fas receptors of uninfected cells and induces apoptosis. | 51 | CHUK(2), LMNB1(1), PTK2(2), RASA1(1), SPTAN1(3), TNFRSF1B(1) | 280016 | 10 | 9 | 10 | 2 | 2 | 1 | 4 | 0 | 3 | 0.62 | 1.00 |
318 | HSA04614_RENIN_ANGIOTENSIN_ SYSTEM | Genes involved in renin-angiotensin system | 17 | ACE2(1), CTSG(1), REN(1) | 80795 | 3 | 3 | 3 | 1 | 1 | 0 | 1 | 1 | 0 | 0.62 | 1.00 |
319 | EIF4PATHWAY | The eIF-4F complex recognizes 5' mRNA caps, recruits RNA helicases, and maintains mRNA-ribosome bridging. | 22 | EIF4G3(4), PRKCA(2) | 95305 | 6 | 6 | 6 | 2 | 3 | 2 | 1 | 0 | 0 | 0.62 | 1.00 |
320 | HSA05050_DENTATORUBROPALLIDOLUYSIAN_ ATROPHY | Genes involved in dentatorubropallidoluysian atrophy (DRPLA) | 15 | INSR(1), MAGI1(3) | 100982 | 4 | 4 | 4 | 1 | 2 | 0 | 1 | 1 | 0 | 0.62 | 1.00 |
321 | HSA00521_STREPTOMYCIN_ BIOSYNTHESIS | Genes involved in streptomycin biosynthesis | 10 | GCK(2), HK1(1) | 76138 | 3 | 3 | 3 | 3 | 0 | 2 | 0 | 1 | 0 | 0.62 | 1.00 |
322 | STREPTOMYCIN_BIOSYNTHESIS | 8 | GCK(2), HK1(1) | 76138 | 3 | 3 | 3 | 3 | 0 | 2 | 0 | 1 | 0 | 0.62 | 1.00 | |
323 | ST_WNT_BETA_CATENIN_ PATHWAY | Beta-catenin is degraded in the absence of Wnt signaling; when extracellular Wnt binds Frizzled receptors, beta-catenin accumulates in the nucleus and may promote cell survival. | 30 | ANKRD6(1), APC(4), AXIN1(1), DVL1(1), LRP1(6), SENP2(1) | 261602 | 14 | 13 | 12 | 4 | 4 | 3 | 5 | 1 | 1 | 0.63 | 1.00 |
324 | CXCR4PATHWAY | CXCR4 is a G-protein coupled receptor that responds to the ligand SDF-1 by activating Ras and PI3 kinase to promote lymphocyte chemotaxis. | 23 | PRKCA(2), PTK2(2), PTK2B(2) | 83230 | 6 | 6 | 6 | 2 | 2 | 3 | 1 | 0 | 0 | 0.63 | 1.00 |
325 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. | 15 | CDK4(1) | 17011 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.63 | 1.00 |
326 | WNTPATHWAY | The Wnt glycoprotein binds to membrane-bound receptors such as Frizzled to activate a number of signaling pathways, including that of beta-catenin. | 23 | APC(4), AXIN1(1), CREBBP(2), DVL1(1) | 141138 | 8 | 8 | 8 | 2 | 1 | 4 | 1 | 1 | 1 | 0.64 | 1.00 |
327 | BENZOATE_DEGRADATION_ VIA_COA_LIGATION | 10 | EHHADH(1), GCDH(1) | 33701 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.64 | 1.00 | |
328 | EGFPATHWAY | The epidermal growth factor (EGF) peptide stimulates the EGF receptor to promote cell proliferation via the MAP kinase and Ras pathways. | 25 | JAK1(1), MAP2K4(1), PRKCA(2), RASA1(1), SOS1(3), STAT1(2) | 180665 | 10 | 9 | 10 | 5 | 4 | 1 | 3 | 1 | 1 | 0.64 | 1.00 |
329 | PDGFPATHWAY | Platelet-derived growth factor (PDGF) receptor is phosphorylated on ligand binding and promotes cell proliferation. | 26 | JAK1(1), MAP2K4(1), PRKCA(2), RASA1(1), SOS1(3), STAT1(2) | 180665 | 10 | 9 | 10 | 5 | 4 | 1 | 3 | 1 | 1 | 0.64 | 1.00 |
330 | REELINPATHWAY | Reelin is secreted by neurons and recognized by receptors including cadherin related neuronal receptors, which promote phosphorylation of Dab1. | 6 | VLDLR(1) | 17102 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.64 | 1.00 |
331 | INOSITOL_PHOSPHATE_ METABOLISM | 22 | PIK3C2A(1), PIK3C2B(2), PLCB4(3), PLCD1(1) | 129707 | 7 | 6 | 7 | 1 | 3 | 2 | 1 | 1 | 0 | 0.64 | 1.00 | |
332 | NUCLEOTIDE_GPCRS | 8 | LTB4R(1) | 57000 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0.64 | 1.00 | |
333 | MPRPATHWAY | Progesterone binding to its intracellular receptor activates the MAPK pathway and induces oocyte maturation; binding to membrane receptor inhibits adenylyl cyclase. | 22 | GNAS(3) | 74967 | 3 | 3 | 3 | 3 | 1 | 0 | 2 | 0 | 0 | 0.65 | 1.00 |
334 | HCMVPATHWAY | Cytomegalovirus activates MAP kinase pathways in the host cell, inducing transcription of viral genes. | 16 | CREB1(1), MAP2K6(1) | 85335 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 1 | 0 | 0.65 | 1.00 |
335 | HSA00290_VALINE_ LEUCINE_AND_ISOLEUCINE_ BIOSYNTHESIS | Genes involved in valine, leucine and isoleucine biosynthesis | 12 | BCAT2(2), LARS(4), LARS2(1), VARS(2) | 234288 | 9 | 9 | 9 | 2 | 1 | 3 | 3 | 2 | 0 | 0.65 | 1.00 |
336 | HSA04330_NOTCH_SIGNALING_ PATHWAY | Genes involved in Notch signaling pathway | 42 | ADAM17(2), CREBBP(2), CTBP2(1), DLL3(1), DVL1(1), DVL3(3), HDAC2(1), MAML1(1), NCOR2(3), NOTCH1(2), NUMB(1), PSENEN(1), RBPJL(2) | 382274 | 21 | 19 | 21 | 7 | 7 | 6 | 5 | 1 | 2 | 0.65 | 1.00 |
337 | GLUCONEOGENESIS | 52 | ADH1B(4), ADH6(2), ALDH3A1(1), DLAT(1), GCK(2), GPI(2), HK1(1), LDHC(1), PFKP(1), PGK1(2) | 301751 | 17 | 17 | 17 | 8 | 3 | 8 | 2 | 2 | 2 | 0.65 | 1.00 | |
338 | GLYCOLYSIS | 52 | ADH1B(4), ADH6(2), ALDH3A1(1), DLAT(1), GCK(2), GPI(2), HK1(1), LDHC(1), PFKP(1), PGK1(2) | 301751 | 17 | 17 | 17 | 8 | 3 | 8 | 2 | 2 | 2 | 0.65 | 1.00 | |
339 | HSA00330_ARGININE_ AND_PROLINE_METABOLISM | Genes involved in arginine and proline metabolism | 33 | NOS3(1) | 73234 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0.65 | 1.00 |
340 | IL2RBPATHWAY | The beta subunit of the IL-2 receptor is required for IL-2 and IL-15 signal recognition and activates JAK kinase on ligand binding. | 34 | JAK1(1), SOS1(3), STAT5B(1) | 124296 | 5 | 5 | 5 | 3 | 2 | 0 | 2 | 1 | 0 | 0.65 | 1.00 |
341 | GLUTAMATE_METABOLISM | 23 | CAD(3) | 75305 | 3 | 3 | 3 | 1 | 0 | 1 | 2 | 0 | 0 | 0.66 | 1.00 | |
342 | GLYOXYLATE_AND_DICARBOXYLATE_ METABOLISM | 12 | GRHPR(1), MTHFD1L(1) | 53961 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0.66 | 1.00 | |
343 | APOPTOSIS_GENMAPP | 42 | MAP2K4(1), PARP1(1), TNFRSF1B(1) | 119297 | 3 | 3 | 3 | 0 | 1 | 0 | 0 | 1 | 1 | 0.66 | 1.00 | |
344 | PELP1PATHWAY | Pelp1 acts downstream of activated estrogen receptor to promote cell proliferation and is overexpressed in many breast tumors. | 7 | CREBBP(2) | 59128 | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 0.67 | 1.00 |
345 | HSA00860_PORPHYRIN_ AND_CHLOROPHYLL_ METABOLISM | Genes involved in porphyrin and chlorophyll metabolism | 41 | BLVRB(1), CP(3), EARS2(2), UGT2B15(1) | 156217 | 7 | 7 | 7 | 0 | 4 | 1 | 2 | 0 | 0 | 0.68 | 1.00 |
346 | HSA04742_TASTE_TRANSDUCTION | Genes involved in taste transduction | 48 | ADCY4(1), ADCY8(7), CACNA1A(1), GNAS(3), ITPR3(4), PDE1A(1) | 297325 | 17 | 15 | 17 | 13 | 4 | 5 | 5 | 1 | 2 | 0.68 | 1.00 |
347 | HSA01430_CELL_COMMUNICATION | Genes involved in cell communication | 129 | COL11A2(2), COL17A1(3), COL4A1(2), COL4A4(5), COL5A3(5), GJA10(2), GJB1(1), GJC2(1), ITGB4(1), KRT13(1), KRT14(1), KRT15(2), KRT3(1), KRT32(2), KRT6B(1), KRT72(2), KRT74(1), KRT75(1), KRT76(2), KRT82(2), KRT9(2), LAMA5(3), LAMB1(4), LAMB2(8), LAMB3(3), LAMC3(3), LMNB1(1), NES(1), TNXB(5) | 1192588 | 68 | 44 | 68 | 17 | 18 | 33 | 9 | 4 | 4 | 0.68 | 1.00 |
348 | CLASSICPATHWAY | The classic complement pathway is initiated by antibodies and promotes phagocytosis and lysis of foreign cells as well as activating the inflammatory response. | 13 | C1QA(1), C2(2), C3(2), C6(2), C7(3), C9(1) | 223531 | 11 | 11 | 11 | 5 | 2 | 7 | 0 | 1 | 1 | 0.68 | 1.00 |
349 | HSA00630_GLYOXYLATE_ AND_DICARBOXYLATE_ METABOLISM | Genes involved in glyoxylate and dicarboxylate metabolism | 13 | GRHPR(1), MTHFD1L(1) | 56347 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0.68 | 1.00 |
350 | GLYCOLYSIS_AND_GLUCONEOGENESIS | Genes involved in glycolysis and gluconeogenesis | 42 | DLAT(1), GCK(2), GPI(2), HK1(1), LDHC(1), PC(1), PFKP(1), PGK1(2) | 222103 | 11 | 11 | 11 | 6 | 1 | 5 | 2 | 2 | 1 | 0.68 | 1.00 |
351 | BOTULINPATHWAY | Blockade of Neurotransmitter Relase by Botulinum Toxin | 5 | CHRNA1(3) | 113596 | 3 | 3 | 3 | 0 | 2 | 0 | 0 | 1 | 0 | 0.69 | 1.00 |
352 | NITROGEN_METABOLISM | 20 | CA9(1) | 41520 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.69 | 1.00 | |
353 | HSA05120_EPITHELIAL_ CELL_SIGNALING_IN_ HELICOBACTER_PYLORI_ INFECTION | Genes involved in epithelial cell signaling in Helicobacter pylori infection | 65 | ADAM17(2), ATP6V1B1(1), ATP6V1H(1), CHUK(2), LYN(1), MAP2K4(1), MET(2) | 282776 | 10 | 8 | 10 | 2 | 2 | 2 | 3 | 0 | 3 | 0.69 | 1.00 |
354 | PORPHYRIN_AND_CHLOROPHYLL_ METABOLISM | 26 | BLVRB(1), CP(3), UGT2B15(1) | 96686 | 5 | 5 | 5 | 0 | 3 | 1 | 1 | 0 | 0 | 0.70 | 1.00 | |
355 | NFATPATHWAY | Cardiac hypertrophy is induced by NF-ATc4 and GATA4, which are stimulated through calcineurin activated by CaMK. | 51 | CAMK4(3), CREBBP(2), ELSPBP1(2), HAND1(1), NFATC3(2), PPP3CC(1) | 184090 | 11 | 9 | 11 | 2 | 4 | 4 | 1 | 1 | 1 | 0.70 | 1.00 |
356 | METHIONINE_METABOLISM | 12 | DNMT1(1), MARS(1) | 39083 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0.70 | 1.00 | |
357 | HSA00930_CAPROLACTAM_ DEGRADATION | Genes involved in caprolactam degradation | 13 | EHHADH(1), HSD17B4(2) | 100640 | 3 | 3 | 3 | 0 | 1 | 1 | 0 | 1 | 0 | 0.71 | 1.00 |
358 | COMPPATHWAY | Both the classic and alternative immune complement pathways promote inflammation, foreign cell lysis, and phagocytosis. | 16 | C1QA(1), C2(2), C3(2), C6(2), C7(3), C9(1) | 229837 | 11 | 11 | 11 | 5 | 2 | 7 | 0 | 1 | 1 | 0.71 | 1.00 |
359 | TRYPTOPHAN_METABOLISM | 53 | ALDH3A1(1), AOC2(1), CYP2A13(2), CYP2C19(1), CYP2E1(1), CYP3A7(3), DDC(2), EHHADH(1), GCDH(1), WARS(1) | 240145 | 14 | 13 | 14 | 5 | 3 | 7 | 2 | 0 | 2 | 0.71 | 1.00 | |
360 | P53PATHWAY | p53 induces cell cycle arrest or apoptosis under conditions of DNA damage. | 15 | CDK4(1) | 21211 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.71 | 1.00 |
361 | HSA00970_AMINOACYL_ TRNA_BIOSYNTHESIS | Genes involved in aminoacyl-tRNA biosynthesis | 38 | AARS2(2), EARS2(2), GARS(1), HARS(1), LARS(4), LARS2(1), MARS(1), NARS2(1), VARS(2), WARS(1) | 399079 | 16 | 14 | 16 | 5 | 3 | 6 | 4 | 3 | 0 | 0.72 | 1.00 |
362 | HSA00251_GLUTAMATE_ METABOLISM | Genes involved in glutamate metabolism | 30 | ADC(1), CAD(3), EARS2(2), GFPT2(2) | 167514 | 8 | 8 | 8 | 2 | 2 | 2 | 3 | 0 | 1 | 0.72 | 1.00 |
363 | VEGFPATHWAY | Vascular endothelial growth factor (VEGF) is upregulated by hypoxic conditions and promotes normal blood vessel formation and angiogenesis related to tumor growth or cardiac disease. | 24 | EIF2B4(2), NOS3(1), PRKCA(2), PTK2(2) | 154636 | 7 | 6 | 7 | 1 | 3 | 2 | 1 | 1 | 0 | 0.72 | 1.00 |
364 | ST_GAQ_PATHWAY | G-alpha-q activates phospholipase C, resulting in calcium influx and increasing protein kinase C activity. | 26 | ITPR1(2), ITPR3(4) | 129682 | 6 | 5 | 6 | 1 | 1 | 3 | 0 | 1 | 1 | 0.73 | 1.00 |
365 | IL1RPATHWAY | The cytokine IL-1 stimulates its primary receptor, IL-1R1, which induces transcription of inflammation-related genes such as interferons. | 31 | CHUK(2), IRAK2(2), IRAK3(2), MAP2K6(1), TOLLIP(1) | 198497 | 8 | 8 | 8 | 0 | 1 | 5 | 0 | 0 | 2 | 0.73 | 1.00 |
366 | IL5PATHWAY | Pro-inflammatory IL-5 is secretes by activated T cells, eosinophils, and mast cells, and stimulates the proliferation and activation of eosinophils in bone marrow. | 10 | IL5RA(1) | 21840 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.73 | 1.00 |
367 | SMOOTH_MUSCLE_CONTRACTION | 133 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), ATP2A3(1), CAMK2A(1), CAMK2B(3), CAMK2D(1), CNN1(1), GRK4(2), GRK6(1), ITPR1(2), ITPR3(4), NOS3(1), PLCD1(1), PRKCA(2), PRKCE(1), TNXB(5) | 842205 | 39 | 26 | 39 | 18 | 12 | 10 | 6 | 5 | 6 | 0.73 | 1.00 | |
368 | HISTIDINE_METABOLISM | 24 | ALDH3A1(1), AOC2(1), DDC(2), HARS(1) | 84983 | 5 | 5 | 5 | 2 | 1 | 2 | 1 | 0 | 1 | 0.74 | 1.00 | |
369 | SETPATHWAY | Cytotoxic T cells release perforin, which to allow entry into target cells of granzyme B, which activates caspases, and granzyme A, which induces caspase-independent apoptosis. | 11 | CREBBP(2) | 70644 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0.74 | 1.00 |
370 | CALCINEURIN_NF_AT_ SIGNALING | Mouse genes associated with signal transduction through calcium, calcineurin, and NF-AT. | 92 | CABIN1(2), CAMK2B(3), CAMK4(3), CREBBP(2), GRLF1(3), KPNA5(1), NFAT5(2), NFATC3(2), PPP3CC(1), PTPRC(6) | 438012 | 25 | 20 | 25 | 3 | 7 | 9 | 4 | 1 | 4 | 0.75 | 1.00 |
371 | COMPLEMENT_ACTIVATION_ CLASSICAL | 15 | C1QA(1), C2(2), C3(2), C6(2), C7(3), C8B(2), C9(1) | 232291 | 13 | 13 | 13 | 5 | 3 | 7 | 1 | 1 | 1 | 0.75 | 1.00 | |
372 | HSA04070_PHOSPHATIDYLINOSITOL_ SIGNALING_SYSTEM | Genes involved in phosphatidylinositol signaling system | 71 | INPP5B(2), INPP5D(1), ITPR1(2), ITPR3(4), PIK3C2A(1), PIK3C2B(2), PIK3R5(2), PLCB4(3), PLCD1(1), PLCD4(2), PLCE1(2), PRKCA(2), SYNJ2(1) | 469000 | 25 | 22 | 25 | 6 | 9 | 9 | 3 | 2 | 2 | 0.76 | 1.00 |
373 | RARRXRPATHWAY | RXR and RAR suppress transcription in the absence of ligand and, on binding trans- or 9-cis-retinoic acid, are ubiquitinated to allow transcription to proceed. | 14 | NCOR2(3), POLR2A(1) | 110901 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.76 | 1.00 |
374 | HSA00271_METHIONINE_ METABOLISM | Genes involved in methionine metabolism | 17 | DNMT1(1), MARS(1), TAT(1) | 55951 | 3 | 3 | 3 | 2 | 1 | 2 | 0 | 0 | 0 | 0.76 | 1.00 |
375 | HSA04710_CIRCADIAN_ RHYTHM | Genes involved in circadian rhythm | 11 | PER1(1) | 51488 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0.77 | 1.00 |
376 | ARGININE_AND_PROLINE_ METABOLISM | 42 | ALDH3A1(1), AOC2(1), NOS3(1) | 104290 | 3 | 3 | 3 | 2 | 1 | 0 | 1 | 1 | 0 | 0.77 | 1.00 | |
377 | HSA00400_PHENYLALANINE_ TYROSINE_AND_TRYPTOPHAN_ BIOSYNTHESIS | Genes involved in phenylalanine, tyrosine and tryptophan biosynthesis | 9 | TAT(1) | 34388 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.77 | 1.00 |
378 | DREAMPATHWAY | The transcription factor DREAM blocks expression of the prodynorphin gene, which encodes the ligand of an opioid receptor that blocks pain signaling. | 13 | CREB1(1), CREM(1), POLR2A(1) | 114928 | 3 | 3 | 3 | 1 | 0 | 2 | 0 | 1 | 0 | 0.78 | 1.00 |
379 | PEPTIDE_GPCRS | 66 | ATP8A1(1), AVPR2(1), CXCR3(1), NPY1R(1), NTSR2(1) | 109775 | 5 | 4 | 5 | 0 | 1 | 2 | 1 | 1 | 0 | 0.78 | 1.00 | |
380 | GLYCOSAMINOGLYCAN_ DEGRADATION | 11 | IDUA(1) | 82992 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.78 | 1.00 | |
381 | HSA00260_GLYCINE_ SERINE_AND_THREONINE_ METABOLISM | Genes involved in glycine, serine and threonine metabolism | 44 | AOC2(1), GARS(1), GCAT(2), GLDC(4), PSPH(1), SARDH(1) | 211763 | 10 | 8 | 10 | 2 | 3 | 4 | 1 | 0 | 2 | 0.78 | 1.00 |
382 | ATMPATHWAY | The tumor-suppressing protein kinase ATM responds to radiation-induced DNA damage by blocking cell-cycle progression and activating DNA repair. | 18 | RAD51(1) | 46232 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.79 | 1.00 |
383 | HSA00980_METABOLISM_ OF_XENOBIOTICS_BY_ CYTOCHROME_P450 | Genes involved in metabolism of xenobiotics by cytochrome P450 | 70 | ADH1B(4), ADH6(2), ALDH3A1(1), CYP2C19(1), CYP2E1(1), CYP3A7(3), DHDH(1), UGT2B15(1) | 268479 | 14 | 12 | 14 | 2 | 5 | 6 | 1 | 0 | 2 | 0.79 | 1.00 |
384 | UBIQUINONE_BIOSYNTHESIS | 15 | NDUFA8(1), NDUFV1(1) | 55241 | 2 | 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0.79 | 1.00 | |
385 | TIDPATHWAY | On ligand binding, interferon gamma receptors stimulate JAK2 kinase to phosphorylate STAT transcription factors, which promote expression of interferon responsive genes. | 18 | JAK2(1), TNFRSF1B(1) | 42505 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.79 | 1.00 |
386 | SA_BONE_MORPHOGENETIC | Bone morphogenetic protein binds to its receptor to induce ectopic bone formation and promote development of the viscera. | 4 | BMP1(1) | 52902 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.79 | 1.00 |
387 | HSA00910_NITROGEN_ METABOLISM | Genes involved in nitrogen metabolism | 23 | CA9(1) | 53020 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0.79 | 1.00 |
388 | HSA04115_P53_SIGNALING_ PATHWAY | Genes involved in p53 signaling pathway | 64 | BAI1(1), CDK4(1), CDK6(1), LRDD(1) | 132055 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 0.80 | 1.00 |
389 | ALANINE_AND_ASPARTATE_ METABOLISM | 21 | CAD(3), PC(1) | 176795 | 4 | 4 | 4 | 1 | 0 | 1 | 3 | 0 | 0 | 0.80 | 1.00 | |
390 | C21_STEROID_HORMONE_ METABOLISM | 11 | CYP11B2(2) | 41064 | 2 | 2 | 2 | 5 | 0 | 2 | 0 | 0 | 0 | 0.80 | 1.00 | |
391 | HSA00140_C21_STEROID_ HORMONE_METABOLISM | Genes involved in C21-steroid hormone metabolism | 11 | CYP11B2(2) | 41064 | 2 | 2 | 2 | 5 | 0 | 2 | 0 | 0 | 0 | 0.80 | 1.00 |
392 | CERAMIDEPATHWAY | Ceramide is a lipid signaling molecule that can activate proliferative or apoptotic pathways, depending on signaling context, localization, and cell type. | 21 | MAP2K4(1) | 88581 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0.80 | 1.00 |
393 | HSA00720_REDUCTIVE_ CARBOXYLATE_CYCLE | Genes involved in reductive carboxylate cycle (CO2 fixation) | 11 | ACLY(2), ACSS1(1) | 102720 | 3 | 3 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0.81 | 1.00 |
394 | ST_DICTYOSTELIUM_ DISCOIDEUM_CAMP_ CHEMOTAXIS_PATHWAY | The fungus Dictyostelium discoideum is a model system for cytoskeletal organization during chemotaxis. | 31 | ITPR1(2), ITPR3(4), RIPK3(1) | 159530 | 7 | 6 | 7 | 2 | 2 | 3 | 0 | 1 | 1 | 0.82 | 1.00 |
395 | HSA03022_BASAL_TRANSCRIPTION_ FACTORS | Genes involved in basal transcription factors | 33 | GTF2H1(1), TAF1(3), TAF2(3), TAF7L(1) | 231533 | 8 | 7 | 8 | 2 | 0 | 2 | 4 | 1 | 1 | 0.82 | 1.00 |
396 | ST_JNK_MAPK_PATHWAY | JNKs are MAP kinases regulated by several levels of kinases (MAPKK, MAPKKK) and phosphorylate transcription factors and regulatory proteins. | 37 | GCK(2), MAP2K4(1), MAP3K12(1), NFATC3(2), ZAK(2) | 275048 | 8 | 6 | 8 | 4 | 0 | 3 | 2 | 2 | 1 | 0.83 | 1.00 |
397 | HSA04320_DORSO_VENTRAL_ AXIS_FORMATION | Genes involved in dorso-ventral axis formation | 24 | NOTCH1(2), SOS1(3) | 181345 | 5 | 5 | 5 | 6 | 2 | 0 | 3 | 0 | 0 | 0.84 | 1.00 |
398 | HSA04610_COMPLEMENT_ AND_COAGULATION_ CASCADES | Genes involved in complement and coagulation cascades | 67 | C1QA(1), C1QC(1), C2(2), C3(2), C6(2), C7(3), C8B(2), C9(1), CFB(1), CFI(3), CR1(3), F5(4), SERPIND1(1) | 467905 | 26 | 23 | 26 | 10 | 7 | 12 | 4 | 1 | 2 | 0.84 | 1.00 |
399 | INTEGRINPATHWAY | Integrins are cell surface receptors commonly present at focal adhensions that interact with the extracellular matrix and transduce extracellular signaling. | 35 | ACTN3(2), BCR(1), ITGA1(1), PPP1R12B(2), PTK2(2), SOS1(3), TLN1(3) | 364069 | 14 | 11 | 14 | 5 | 3 | 5 | 3 | 0 | 3 | 0.84 | 1.00 |
400 | HSA00590_ARACHIDONIC_ ACID_METABOLISM | Genes involved in arachidonic acid metabolism | 51 | ALOX12B(1), CYP2C19(1), CYP2E1(1), PLA2G4A(3) | 118988 | 6 | 5 | 6 | 2 | 1 | 4 | 1 | 0 | 0 | 0.84 | 1.00 |
401 | HSA00920_SULFUR_ METABOLISM | Genes involved in sulfur metabolism | 14 | PAPSS2(1), SULT1A2(1) | 44022 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.84 | 1.00 |
402 | SULFUR_METABOLISM | 9 | PAPSS2(1), SULT1A2(1) | 44022 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.84 | 1.00 | |
403 | GSK3PATHWAY | Bacterial lipopolysaccharide activates AKT to promote the survival and activation of macrophages and inhibits Gsk3-beta to promote beta-catenin accumulation in the nucleus. | 26 | APC(4), AXIN1(1), DVL1(1), TOLLIP(1) | 147909 | 7 | 7 | 7 | 1 | 2 | 3 | 1 | 1 | 0 | 0.85 | 1.00 |
404 | AMINOSUGARS_METABOLISM | 15 | GCK(2), HK1(1), RENBP(1) | 147706 | 4 | 4 | 4 | 2 | 0 | 2 | 1 | 1 | 0 | 0.85 | 1.00 | |
405 | PGC1APATHWAY | PCG-1a is expressed in skeletal muscle, heart muscle, and brown fat, and is a coactivator for receptors such as glucocorticoid receptor and thyroid hormone receptor. | 23 | CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), HDAC5(1), PPP3CC(1) | 274413 | 10 | 8 | 10 | 2 | 5 | 3 | 1 | 0 | 1 | 0.87 | 1.00 |
406 | BLOOD_CLOTTING_CASCADE | 19 | F5(4) | 80757 | 4 | 4 | 4 | 5 | 1 | 2 | 1 | 0 | 0 | 0.87 | 1.00 | |
407 | ECMPATHWAY | Extracellular matrix induces integrin-mediated FAK phosphorylation in epithelial cells, leading to PI3 and MAP kinase activation and actin reorganization. | 22 | ITGA1(1), MYLK(4), PTK2(2), TLN1(3) | 246912 | 10 | 10 | 10 | 4 | 2 | 5 | 1 | 0 | 2 | 0.87 | 1.00 |
408 | MAPKPATHWAY | The mitogen-activated protein (MAP) kinase pathway is a common signaling mechanism and has four main sub-pathways: Erk, JNK/SAPK, p53, and ERK5. | 84 | CHUK(2), CREB1(1), MAP2K4(1), MAP2K6(1), MAP3K12(1), MAP4K3(1), MAPKAPK2(1), RPS6KA2(1), RPS6KA4(1), STAT1(2) | 495340 | 12 | 12 | 12 | 6 | 2 | 5 | 0 | 1 | 4 | 0.87 | 1.00 |
409 | CALCIUM_REGULATION_ IN_CARDIAC_CELLS | 132 | ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), ATP2A3(1), ATP2B1(1), ATP2B2(4), CACNA1A(1), CACNA1D(6), CAMK2A(1), CAMK2B(3), CAMK2D(1), CAMK4(3), GJB1(1), GNA11(1), GRK4(2), GRK6(1), ITPR1(2), ITPR3(4), PRKCA(2), PRKCE(1), SLC8A3(4) | 1033938 | 52 | 36 | 52 | 19 | 16 | 16 | 11 | 2 | 7 | 0.87 | 1.00 | |
410 | HSA00562_INOSITOL_ PHOSPHATE_METABOLISM | Genes involved in inositol phosphate metabolism | 46 | INPP5B(2), PLCB4(3), PLCD1(1), PLCD4(2), PLCE1(2), SYNJ2(1) | 213570 | 11 | 10 | 11 | 2 | 4 | 4 | 2 | 0 | 1 | 0.88 | 1.00 |
411 | EPOPATHWAY | Erythropoietin, which activates the MAPK pathway, stimulates erythrocyte production and is an effective treatment for anemia. | 19 | JAK2(1), SOS1(3), STAT5B(1) | 124198 | 5 | 5 | 5 | 2 | 2 | 1 | 2 | 0 | 0 | 0.88 | 1.00 |
412 | HSA04350_TGF_BETA_ SIGNALING_PATHWAY | Genes involved in TGF-beta signaling pathway | 89 | ACVR1C(1), ACVRL1(1), CREBBP(2), ID3(1), INHBC(1), NODAL(1), PPP2R2A(2), RBL1(1), SMURF1(1), SMURF2(2) | 371983 | 13 | 13 | 13 | 6 | 4 | 3 | 3 | 2 | 1 | 0.88 | 1.00 |
413 | UBIQUITIN_MEDIATED_ PROTEOLYSIS | 23 | NRF1(1), UBE2L6(1) | 48382 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0.88 | 1.00 | |
414 | FMLPPATHWAY | The fMLP receptor is a G-protein coupled receptor in neutrophils that recognizes formylated bacterial peptides and activates NADPH oxidase. | 36 | MAP2K6(1), NFATC3(2), PPP3CC(1) | 190024 | 4 | 3 | 4 | 1 | 1 | 1 | 1 | 1 | 0 | 0.88 | 1.00 |
415 | HSA00010_GLYCOLYSIS_ AND_GLUCONEOGENESIS | Genes involved in glycolysis and gluconeogenesis | 63 | ACSS1(1), ADH1B(4), ADH6(2), ALDH3A1(1), DLAT(1), GCK(2), GPI(2), HK1(1), LDHC(1), PFKP(1), PGK1(2) | 360570 | 18 | 18 | 18 | 9 | 4 | 8 | 2 | 2 | 2 | 0.88 | 1.00 |
416 | CITRATE_CYCLE_TCA_ CYCLE | 19 | IDH3B(1), PC(1) | 108303 | 2 | 2 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0.88 | 1.00 | |
417 | PENTOSE_AND_GLUCURONATE_ INTERCONVERSIONS | 18 | UGT2B15(1) | 47249 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.88 | 1.00 | |
418 | HSA00150_ANDROGEN_ AND_ESTROGEN_METABOLISM | Genes involved in androgen and estrogen metabolism | 54 | ARSD(2), CYP11B2(2), HSD17B12(1), UGT2B15(1) | 172990 | 6 | 6 | 6 | 5 | 1 | 5 | 0 | 0 | 0 | 0.89 | 1.00 |
419 | HSA00511_N_GLYCAN_ DEGRADATION | Genes involved in N-glycan degradation | 15 | MAN2B1(2) | 160821 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0.89 | 1.00 |
420 | MCALPAINPATHWAY | In integrin-mediated cell migration, calpains digest links between the actin cytoskeleton and focal adhesion proteins. | 23 | CXCR3(1), ITGA1(1), MYLK(4), PTK2(2), TLN1(3) | 254604 | 11 | 11 | 11 | 4 | 3 | 5 | 1 | 0 | 2 | 0.89 | 1.00 |
421 | CHEMICALPATHWAY | DNA damage promotes Bid cleavage, which stimulates mitochondrial cytochrome c release and consequent caspase activation, resulting in apoptosis. | 19 | PRKCA(2), PTK2(2), STAT1(2), TLN1(3) | 221625 | 9 | 8 | 9 | 2 | 4 | 3 | 1 | 0 | 1 | 0.89 | 1.00 |
422 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling | 33 | MAP2K4(1), MAPK8IP1(1) | 111108 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 1 | 0.89 | 1.00 |
423 | INSULINPATHWAY | Insulin regulates glucose levels via Ras-mediated transcriptional activation. | 21 | INSR(1), RASA1(1), SOS1(3) | 267761 | 5 | 5 | 5 | 4 | 1 | 0 | 4 | 0 | 0 | 0.89 | 1.00 |
424 | ST_P38_MAPK_PATHWAY | p38 is a MAP kinase regulated by cytokines and cellular stress. | 35 | CREB1(1), MAP2K4(1), MAP2K6(1), MAPKAPK2(1) | 175171 | 4 | 4 | 4 | 0 | 1 | 1 | 0 | 1 | 1 | 0.89 | 1.00 |
425 | TELPATHWAY | Telomerase is a ribonucleotide protein that adds telomeric repeats to the 3' ends of chromosomes. | 14 | POLR2A(1), PRKCA(2), TERT(1) | 102849 | 4 | 4 | 4 | 2 | 2 | 2 | 0 | 0 | 0 | 0.90 | 1.00 |
426 | CELLCYCLEPATHWAY | Cyclins interact with cyclin-dependent kinases to form active kinase complexes that regulate progression through the cell cycle. | 22 | CDK4(1), CDK6(1), RBL1(1) | 80783 | 3 | 3 | 3 | 0 | 2 | 1 | 0 | 0 | 0 | 0.90 | 1.00 |
427 | HSA00410_BETA_ALANINE_ METABOLISM | Genes involved in beta-alanine metabolism | 25 | ALDH3A1(1), AOC2(1), DPYS(3), EHHADH(1) | 113400 | 6 | 6 | 6 | 3 | 2 | 3 | 1 | 0 | 0 | 0.90 | 1.00 |
428 | NKCELLSPATHWAY | Natural killer (NK) lymphocytes are inhibited by MHC and activated by surface glycoproteins on tumor or virus-infected cells, which undergo perforin-mediated lysis. | 20 | LAT(1), PTK2B(2) | 82934 | 3 | 3 | 3 | 2 | 1 | 2 | 0 | 0 | 0 | 0.91 | 1.00 |
429 | ALKALOID_BIOSYNTHESIS_ II | 5 | AOC2(1) | 54507 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0.91 | 1.00 | |
430 | GPCRDB_OTHER | 52 | CELSR1(2), CELSR3(6), CXCR3(1), EMR2(1), EMR3(2), GPR116(1), GPR61(1), LGR6(2), OR8G2(2) | 365484 | 18 | 15 | 18 | 6 | 5 | 8 | 2 | 2 | 1 | 0.91 | 1.00 | |
431 | ANDROGEN_AND_ESTROGEN_ METABOLISM | 30 | ARSD(2), CYP11B2(2), UGT2B15(1) | 134103 | 5 | 5 | 5 | 5 | 1 | 4 | 0 | 0 | 0 | 0.91 | 1.00 | |
432 | N_GLYCAN_BIOSYNTHESIS | 21 | B4GALT3(1), FUT8(2), MAN1B1(2) | 120489 | 5 | 5 | 5 | 0 | 1 | 2 | 1 | 0 | 1 | 0.91 | 1.00 | |
433 | DNAFRAGMENTPATHWAY | DNA fragmentation during apoptosis is effected by DFF, a caspase-activated DNAse, and by endonuclease G. | 10 | TOP2A(1) | 67930 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.91 | 1.00 |
434 | UCALPAINPATHWAY | Calpains promote formation of integrin adhesion clusters which recruit Rac to enable the formation of mature focal adhesions that do not contain calpain. | 16 | ACTN3(2), ITGA1(1), PTK2(2), SPTAN1(3), TLN1(3) | 276574 | 11 | 10 | 11 | 2 | 3 | 3 | 3 | 0 | 2 | 0.91 | 1.00 |
435 | HSA00220_UREA_CYCLE_ AND_METABOLISM_OF_ AMINO_GROUPS | Genes involved in urea cycle and metabolism of amino groups | 29 | ADC(1), ALDH3A1(1), AOC2(1) | 121985 | 3 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 0.91 | 1.00 |
436 | HSA00040_PENTOSE_ AND_GLUCURONATE_ INTERCONVERSIONS | Genes involved in pentose and glucuronate interconversions | 25 | UGT2B15(1) | 54209 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.92 | 1.00 |
437 | HSA00532_CHONDROITIN_ SULFATE_BIOSYNTHESIS | Genes involved in chondroitin sulfate biosynthesis | 17 | CHPF(1) | 96790 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0.92 | 1.00 |
438 | ATRBRCAPATHWAY | BRCA1 and 2 block cell cycle progression in response to DNA damage and promote double-stranded break repair; mutations induce breast cancer susceptibility. | 20 | FANCG(2), RAD51(1) | 140758 | 3 | 3 | 3 | 1 | 0 | 0 | 2 | 0 | 1 | 0.93 | 1.00 |
439 | KREBS_TCA_CYCLE | 29 | DLAT(1), IDH3B(1), OGDH(1), PC(1) | 128223 | 4 | 4 | 4 | 0 | 0 | 2 | 2 | 0 | 0 | 0.93 | 1.00 | |
440 | NUCLEAR_RECEPTORS | 39 | NR0B1(2), NR1H3(2), RORC(1), THRB(1) | 172862 | 6 | 6 | 6 | 2 | 2 | 3 | 0 | 1 | 0 | 0.93 | 1.00 | |
441 | HSA00252_ALANINE_ AND_ASPARTATE_METABOLISM | Genes involved in alanine and aspartate metabolism | 32 | AARS2(2), CAD(3), DLAT(1), NARS2(1), PC(1) | 233344 | 8 | 7 | 8 | 2 | 1 | 3 | 3 | 1 | 0 | 0.93 | 1.00 |
442 | IRINOTECAN_PATHWAY_ PHARMGKB | 17 | ABCC1(1), ABCC2(1) | 91068 | 2 | 2 | 2 | 4 | 0 | 2 | 0 | 0 | 0 | 0.93 | 1.00 | |
443 | CELL_CYCLE_KEGG | 80 | CDH1(1), CDK4(1), HDAC2(1), HDAC5(1), MCM2(1), ORC2L(1), ORC3L(2), PLK1(1), RBL1(1), SKP2(2), TBC1D8(2) | 277655 | 14 | 12 | 14 | 3 | 5 | 6 | 2 | 1 | 0 | 0.93 | 1.00 | |
444 | LYSINE_DEGRADATION | 31 | ALDH3A1(1), DOT1L(1), EHHADH(1), GCDH(1) | 119345 | 4 | 4 | 4 | 1 | 2 | 1 | 1 | 0 | 0 | 0.94 | 1.00 | |
445 | PYRIMIDINE_METABOLISM | 54 | CAD(3), DPYS(3), NT5E(1), POLD1(2), POLR2A(1), POLR2G(1), RRM1(1) | 380776 | 12 | 11 | 12 | 2 | 1 | 5 | 5 | 0 | 1 | 0.94 | 1.00 | |
446 | PURINE_METABOLISM | 108 | ADA(1), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), ENPP3(2), GUCY2C(3), IMPDH2(1), NT5E(1), PAPSS2(1), PDE1A(1), PDE4C(2), PDE6C(2), PDE7B(1), PDE8A(1), PFAS(1), POLD1(2), POLR2A(1), POLR2G(1), RRM1(1) | 772479 | 35 | 26 | 35 | 12 | 6 | 14 | 8 | 2 | 5 | 0.94 | 1.00 | |
447 | HSA00380_TRYPTOPHAN_ METABOLISM | Genes involved in tryptophan metabolism | 58 | ALDH3A1(1), AOC2(1), DDC(2), EHHADH(1), GCDH(1), HSD17B4(2), OGDH(1), WARS(1) | 212346 | 10 | 10 | 10 | 3 | 3 | 3 | 2 | 1 | 1 | 0.94 | 1.00 |
448 | HSA00340_HISTIDINE_ METABOLISM | Genes involved in histidine metabolism | 41 | ALDH3A1(1), AOC2(1), DDC(2), HARS(1) | 137011 | 5 | 5 | 5 | 2 | 1 | 2 | 1 | 0 | 1 | 0.94 | 1.00 |
449 | G1_TO_S_CELL_CYCLE_ REACTOME | 64 | CDK4(1), CREB3L3(1), MCM2(1), ORC2L(1), ORC3L(2), POLA2(1), RBL1(1), TNXB(5) | 395596 | 13 | 10 | 13 | 3 | 3 | 5 | 2 | 2 | 1 | 0.94 | 1.00 | |
450 | HSA00533_KERATAN_ SULFATE_BIOSYNTHESIS | Genes involved in keratan sulfate biosynthesis | 16 | B4GALT3(1), FUT8(2) | 80233 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 0.95 | 1.00 |
451 | HSA00564_GLYCEROPHOSPHOLIPID_ METABOLISM | Genes involved in glycerophospholipid metabolism | 64 | GPAM(1), PLA2G4A(3) | 143737 | 4 | 3 | 4 | 2 | 1 | 1 | 2 | 0 | 0 | 0.96 | 1.00 |
452 | HSA00790_FOLATE_ BIOSYNTHESIS | Genes involved in folate biosynthesis | 40 | ALPP(1), DDX4(1), DDX54(1), GGH(2), RUVBL2(1), SETX(1), SKIV2L2(2) | 298930 | 9 | 8 | 9 | 3 | 3 | 2 | 1 | 1 | 2 | 0.96 | 1.00 |
453 | HSA00230_PURINE_ METABOLISM | Genes involved in purine metabolism | 140 | ADA(1), ADCY3(1), ADCY4(1), ADCY5(4), ADCY8(7), AK7(3), ENPP3(2), GUCY2C(3), IMPDH2(1), NT5E(1), PAPSS2(1), PDE1A(1), PDE4C(2), PDE7B(1), PDE8A(1), PFAS(1), POLA2(1), POLD1(2), POLR2A(1), POLR2G(1), RRM1(1) | 815439 | 37 | 26 | 37 | 11 | 7 | 14 | 10 | 2 | 4 | 0.97 | 1.00 |
454 | ACETYLCHOLINE_SYNTHESIS | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
455 | BBCELLPATHWAY | Fas ligand expression by T cells induces apoptosis in Fas-expressing, inactive B cells. | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
456 | BLOOD_GROUP_GLYCOLIPID_ BIOSYNTHESIS_NEOLACTOSERIES | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
457 | CK1PATHWAY | Caseine kinase 1 (CK1) and cdk5 phosphorylate DARPP32 in the dopamine signaling pathway. | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
458 | CYANOAMINO_ACID_ METABOLISM | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
459 | EOSINOPHILSPATHWAY | Recruitment of eosinophils in the inflammatory response observed in asthma occurs via the chemoattractant eotaxin binding to the CCR3 receptor. | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
460 | ERYTHPATHWAY | Erythropoietin selectively stimulates erythrocyte differentiation from CFU-GEMM cells in bone marrow. | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
461 | HSA00031_INOSITOL_ METABOLISM | Genes involved in inositol metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
462 | HSA00072_SYNTHESIS_ AND_DEGRADATION_ OF_KETONE_BODIES | Genes involved in synthesis and degradation of ketone bodies | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
463 | HSA00300_LYSINE_ BIOSYNTHESIS | Genes involved in lysine biosynthesis | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
464 | HSA00471_D_GLUTAMINE_ AND_D_GLUTAMATE_ METABOLISM | Genes involved in D-glutamine and D-glutamate metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
465 | HSA00472_D_ARGININE_ AND_D_ORNITHINE_ METABOLISM | Genes involved in D-arginine and D-ornithine metabolism | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
466 | HSA00550_PEPTIDOGLYCAN_ BIOSYNTHESIS | Genes involved in peptidoglycan biosynthesis | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
467 | HSA00627_1,4_DICHLOROBENZENE_ DEGRADATION | Genes involved in 1,4-dichlorobenzene degradation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
468 | HSA00643_STYRENE_ DEGRADATION | Genes involved in styrene degradation | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
469 | HSA00660_C5_BRANCHED_ DIBASIC_ACID_METABOLISM | Genes involved in C5-branched dibasic acid metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
470 | HSA00780_BIOTIN_ METABOLISM | Genes involved in biotin metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
471 | HSA00785_LIPOIC_ ACID_METABOLISM | Genes involved in lipoic acid metabolism | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
472 | HSA00830_RETINOL_ METABOLISM | Genes involved in retinol metabolism | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
473 | IL18PATHWAY | Pro-inflammatory IL-18 is activated in macrophages by caspase-1 cleavage and, in conjunction with IL-12, stimulates Th1 cell differentiation. | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
474 | INOSITOL_METABOLISM | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
475 | LONGEVITYPATHWAY | Caloric restriction in animals often increases lifespan, which may occur via decreased IGF receptor expression and consequent expression of stress-resistance proteins. | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
476 | LYSINE_BIOSYNTHESIS | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
477 | METHIONINEPATHWAY | Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
478 | MTA3PATHWAY | The estrogen receptor regulates proliferation in mammary epithelia via MTA3 activation; loss of either protein is implicated in breast cancer. | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
479 | NEUROTRANSMITTERSPATHWAY | Biosynthesis of neurotransmitters | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
480 | PEPIPATHWAY | Proepithelin (PEPI) induces epithelial cells to secrete IL-8, which promotes elastase secretion by neutrophils. | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
481 | RANPATHWAY | RanGEF (aka RCC1) and RanGFP regulate the GTP- or GDP-bound state of Ran, creating a Ran gradient across the nuclear membrane that is used in nuclear import. | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
482 | SLRPPATHWAY | Small leucine-rich proteoglycans (SLRPs) interact with and reorganize collagen fibers in the extracellular matrix. | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
483 | ST_PAC1_RECEPTOR_ PATHWAY | The signaling peptide PACAP binds to its receptor, PAC1R, which activates adenylyl cyclase and phospholipase C. | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
484 | SYNTHESIS_AND_DEGRADATION_ OF_KETONE_BODIES | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
485 | VOBESITYPATHWAY | The adipose tissue of obese individuals overexpresses a key glucocorticoid-metabolizing enzyme, activating inactive circulating corticosteroids and inducing insulin resistance. | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
486 | HSA03320_PPAR_SIGNALING_ PATHWAY | Genes involved in PPAR signaling pathway | 67 | ACSL3(1), ACSL5(1), CD36(1), EHHADH(1), NR1H3(2), SLC27A1(1), SLC27A4(1), SORBS1(3) | 228563 | 11 | 11 | 11 | 2 | 3 | 5 | 2 | 0 | 1 | 1.00 | 1.00 |
487 | BETA_ALANINE_METABOLISM | 27 | ALDH3A1(1), AOC2(1), DPYS(3), EHHADH(1) | 137520 | 6 | 6 | 6 | 4 | 2 | 3 | 1 | 0 | 0 | 1.00 | 1.00 | |
488 | CELL2CELLPATHWAY | Epithelial cell adhesion proteins such as cadherins transduce signals into the cell via catenins, which alter cell shape and motility. | 13 | ACTN3(2), PTK2(2) | 94258 | 4 | 3 | 4 | 0 | 1 | 2 | 1 | 0 | 0 | 1.00 | 1.00 |
489 | HSA04110_CELL_CYCLE | Genes involved in cell cycle | 108 | CDK4(1), CDK6(1), CREBBP(2), HDAC2(1), MCM2(1), ORC2L(1), ORC3L(2), PLK1(1), RBL1(1), SKP2(2), SMC1A(1) | 349429 | 14 | 13 | 14 | 1 | 4 | 5 | 3 | 1 | 1 | 1.00 | 1.00 |
490 | GLYCEROPHOSPHOLIPID_ METABOLISM | 49 | AGPS(1), PLA2G4A(3) | 102461 | 4 | 3 | 4 | 1 | 1 | 2 | 1 | 0 | 0 | 1.00 | 1.00 | |
491 | PROSTAGLANDIN_SYNTHESIS_ REGULATION | 29 | PLA2G4A(3) | 83884 | 3 | 2 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 1.00 | 1.00 | |
492 | HSA01030_GLYCAN_ STRUCTURES_BIOSYNTHESIS_ 1 | Genes involved in glycan structures - biosynthesis 1 | 108 | B4GALT3(1), CHPF(1), EXT2(1), EXTL1(1), FUT8(2), GALNT7(1), GALNT8(1), GALNTL2(2), GANAB(1), MAN1B1(2), NDST2(2), OGT(2) | 477602 | 17 | 14 | 17 | 7 | 4 | 7 | 3 | 2 | 1 | 1.00 | 1.00 |
493 | KERATAN_SULFATE_ BIOSYNTHESIS | 10 | B4GALT3(1), FUT8(2) | 91211 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 1.00 | 1.00 | |
494 | HSA00903_LIMONENE_ AND_PINENE_DEGRADATION | Genes involved in limonene and pinene degradation | 26 | ALDH3A1(1), CYP2C19(1), EHHADH(1) | 92466 | 3 | 3 | 3 | 3 | 0 | 2 | 1 | 0 | 0 | 1.00 | 1.00 |
495 | MRNA_PROCESSING_ REACTOME | 92 | DDIT3(1), DDX20(1), DHX8(2), POLR2A(1), PPM1G(1), PRPF3(1), RBM5(1), SF3B1(2), SFRS14(1), SRRM1(2), SUPT5H(2) | 465108 | 15 | 12 | 15 | 4 | 7 | 3 | 3 | 2 | 0 | 1.00 | 1.00 | |
496 | TRANSLATION_FACTORS | 37 | EIF2AK1(2), EIF2B4(2), EIF4G3(4) | 251080 | 8 | 8 | 8 | 0 | 4 | 3 | 1 | 0 | 0 | 1.00 | 1.00 | |
497 | CARM_ERPATHWAY | Methyltransferase CARM1 methylates CBP and co-activates estrogen receptors via Grip1. | 26 | CREBBP(2), HDAC2(1), HDAC5(1), NCOR2(3), NR0B1(2), POLR2A(1) | 317724 | 10 | 10 | 10 | 5 | 4 | 4 | 0 | 1 | 1 | 1.00 | 1.00 |
498 | HSA00240_PYRIMIDINE_ METABOLISM | Genes involved in pyrimidine metabolism | 86 | CAD(3), DPYS(3), NT5E(1), POLA2(1), POLD1(2), POLR2A(1), POLR2G(1), RRM1(1) | 431484 | 13 | 11 | 13 | 2 | 1 | 6 | 5 | 0 | 1 | 1.00 | 1.00 |
499 | RHOPATHWAY | RhoA is a G protein whose active form stabilizes actin structures such as focal adhesions and activates Rock1, which phosphorylates myosin light chains. | 30 | ARHGEF11(2), MYLK(4), PPP1R12B(2), TLN1(3) | 371849 | 11 | 9 | 11 | 2 | 3 | 5 | 1 | 0 | 2 | 1.00 | 1.00 |
500 | HSA00510_N_GLYCAN_ BIOSYNTHESIS | Genes involved in N-glycan biosynthesis | 41 | B4GALT3(1), FUT8(2), GANAB(1), MAN1B1(2) | 210505 | 6 | 5 | 6 | 2 | 1 | 3 | 1 | 0 | 1 | 1.00 | 1.00 |
501 | RACCYCDPATHWAY | Ras, Rac, and Rho coordinate to induce cyclin D1 expression and activate cdk2 to promote the G1/S transition. | 22 | CDK4(1), CDK6(1) | 72902 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
502 | GHPATHWAY | Growth hormone receptors dimerize on ligand binding and activate the JAK2 protein kinase. | 25 | INSR(1), JAK2(1), PRKCA(2), SOS1(3), STAT5B(1) | 292491 | 8 | 8 | 8 | 4 | 4 | 1 | 3 | 0 | 0 | 1.00 | 1.00 |
503 | PHOSPHATIDYLINOSITOL_ SIGNALING_SYSTEM | 81 | ACVRL1(1), AURKB(1), PIK3C2A(1), PIK3C2B(2), PLCB4(3), PLCD1(1), PRKCA(2), PRKCE(1), RPS6KA2(1), RPS6KA4(1) | 522214 | 14 | 13 | 14 | 3 | 6 | 4 | 3 | 1 | 0 | 1.00 | 1.00 | |
504 | HSA00450_SELENOAMINO_ ACID_METABOLISM | Genes involved in selenoamino acid metabolism | 26 | MARS(1), PAPSS2(1) | 77082 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
505 | HDACPATHWAY | Myocyte enhancer factor MEF2 activates transcription of genes required for muscle cell differentiation and is inhibited by histone deacetylases. | 30 | CABIN1(2), HDAC5(1), INSR(1), MAP2K6(1), PPP3CC(1) | 248450 | 6 | 5 | 6 | 2 | 2 | 1 | 2 | 0 | 1 | 1.00 | 1.00 |
506 | HSA03050_PROTEASOME | Genes involved in proteasome | 22 | PSMB5(1), PSMB6(1), PSMD1(1) | 125330 | 3 | 3 | 3 | 0 | 1 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
507 | HSA00530_AMINOSUGARS_ METABOLISM | Genes involved in aminosugars metabolism | 29 | GFPT2(2), HK1(1), RENBP(1) | 169013 | 4 | 4 | 4 | 2 | 1 | 2 | 1 | 0 | 0 | 1.00 | 1.00 |
508 | OVARIAN_INFERTILITY_ GENES | 24 | CDK4(1), NCOR1(1), ZP2(1) | 132922 | 3 | 2 | 3 | 3 | 1 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
509 | OXIDATIVE_PHOSPHORYLATION | 60 | ATP6V1B1(1), ATP6V1H(1), ATP7A(2), NDUFA8(1), NDUFV1(1) | 273078 | 6 | 5 | 6 | 0 | 2 | 4 | 0 | 0 | 0 | 1.00 | 1.00 | |
510 | ST_GA13_PATHWAY | G-alpha-13 influences the actin cytoskeleton and activates protein kinase D, PI3K, and Pyk2. | 34 | ARHGEF11(2), MAP2K4(1), PTK2(2) | 234137 | 5 | 4 | 5 | 0 | 1 | 1 | 2 | 0 | 1 | 1.00 | 1.00 |
511 | SMALL_LIGAND_GPCRS | 14 | DNMT1(1) | 47323 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
512 | HSA00632_BENZOATE_ DEGRADATION_VIA_ COA_LIGATION | Genes involved in benzoate degradation via CoA ligation | 24 | EHHADH(1), GCDH(1) | 98471 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
513 | O_GLYCAN_BIOSYNTHESIS | 13 | GALNT7(1), GALNT8(1) | 101048 | 2 | 2 | 2 | 3 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
514 | KREBPATHWAY | The Krebs (citric acid) cycle takes place in mitochondria, where it extracts energy in the form of electron carriers NADH and FADH2, which drive the electron transport chain. | 8 | OGDH(1) | 51360 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
515 | PROTEASOMEPATHWAY | Ubiquitinated proteins are targeted for proteolytic degradation by the proteasome, where they are unfolded and degraded to small peptides in an ATP-dependent process. | 20 | PSMB5(1), PSMB6(1) | 102756 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
516 | EPONFKBPATHWAY | The cytokine erythropoietin (Epo) prevents stress-induced neuronal apoptosis by stimulating anti-apoptotic pathways through JAK2 kinase and NF-kB. | 11 | JAK2(1) | 52166 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
517 | HSA04612_ANTIGEN_ PROCESSING_AND_PRESENTATION | Genes involved in antigen processing and presentation | 73 | CREB1(1), IFNA16(2), TAP2(1) | 231900 | 4 | 4 | 4 | 1 | 1 | 2 | 0 | 1 | 0 | 1.00 | 1.00 |
518 | HSA00531_GLYCOSAMINOGLYCAN_ DEGRADATION | Genes involved in glycosaminoglycan degradation | 17 | HGSNAT(3), IDUA(1) | 232972 | 4 | 4 | 4 | 1 | 2 | 1 | 0 | 0 | 1 | 1.00 | 1.00 |
519 | PROTEASOME | 17 | PSMB5(1), PSMB6(1) | 117396 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
520 | PARKINPATHWAY | In Parkinson's disease, dopaminergic neurons contain Lewy bodies consisting of alpha-synuclein and parkin, an E3 ubiquitin ligase that targets glycosylated alpha-synuclein. | 10 | SNCAIP(1), UBE2L6(1) | 120600 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
521 | HSA01032_GLYCAN_ STRUCTURES_DEGRADATION | Genes involved in degradation of glycan structures | 29 | HGSNAT(3), IDUA(1), MAN2B1(2) | 372793 | 6 | 6 | 6 | 1 | 3 | 1 | 0 | 1 | 1 | 1.00 | 1.00 |
522 | HSA00602_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_NEO_ LACTOSERIES | Genes involved in glycosphingolipid biosynthesis - neo-lactoseries | 21 | B4GALT3(1) | 64325 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
523 | SA_MMP_CYTOKINE_ CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. | 15 | TNFRSF1B(1) | 67679 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
524 | SODDPATHWAY | Some members of the tumor necrosis factor receptor family have cytoplasmic death domains that promote apoptosis when active and are repressed by silencers called SODDs. | 10 | TNFRSF1B(1) | 71135 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
525 | HSA00190_OXIDATIVE_ PHOSPHORYLATION | Genes involved in oxidative phosphorylation | 113 | ATP4A(1), ATP6V1B1(1), ATP6V1H(1), NDUFA8(1), NDUFV1(1) | 357203 | 5 | 3 | 5 | 2 | 1 | 3 | 0 | 0 | 1 | 1.00 | 1.00 |
526 | CAPROLACTAM_DEGRADATION | 5 | EHHADH(1) | 72083 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
527 | ATP_SYNTHESIS | 21 | ATP6V1B1(1), ATP6V1H(1) | 147053 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
528 | FLAGELLAR_ASSEMBLY | 21 | ATP6V1B1(1), ATP6V1H(1) | 147053 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
529 | PHOTOSYNTHESIS | 22 | ATP6V1B1(1), ATP6V1H(1) | 147053 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
530 | TYPE_III_SECRETION_ SYSTEM | 21 | ATP6V1B1(1), ATP6V1H(1) | 147053 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 | |
531 | GLYCOSPHINGOLIPID_ METABOLISM | 23 | ARSD(2) | 148004 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
532 | SARSPATHWAY | The SARS coronavirus has a 30kb RNA genome containing rep, a large gene encoding viral protease Mpro. | 10 | LDHC(1) | 75393 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 1.00 | 1.00 |
533 | PHENYLALANINE_TYROSINE_ AND_TRYPTOPHAN_BIOSYNTHESIS | 9 | TAT(1) | 76018 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
534 | RBPATHWAY | The ATM protein kinase recognizes DNA damage and blocks cell cycle progression by phosphorylating chk1 and p53, which normally inhibits Rb to allow G1/S transitions. | 11 | CDK4(1) | 79021 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
535 | ST_TUMOR_NECROSIS_ FACTOR_PATHWAY | Tumor necrosis factor is a pro-inflammatory cytokine that activates NF-kB and c-Jun. | 28 | MAP2K4(1), TNFRSF1B(1) | 158339 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1.00 | 1.00 |
536 | MSPPATHWAY | Macrophage stimulating protein is synthesized as pro-MSP by the liver and, on proteolysis, binds to monocyte receptor kinase RON to induce macrophage development. | 6 | MST1(1), MST1R(1) | 159790 | 2 | 2 | 2 | 3 | 1 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
537 | HSA00960_ALKALOID_ BIOSYNTHESIS_II | Genes involved in alkaloid biosynthesis II | 18 | AOC2(1) | 80434 | 1 | 1 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
538 | HSA00600_SPHINGOLIPID_ METABOLISM | Genes involved in sphingolipid metabolism | 36 | ARSD(2) | 161842 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
539 | RNA_TRANSCRIPTION_ REACTOME | 37 | GTF2H1(1), POLR2A(1), POLR2G(1) | 273641 | 3 | 3 | 3 | 0 | 0 | 2 | 1 | 0 | 0 | 1.00 | 1.00 | |
540 | RIBOSOMAL_PROTEINS | 94 | RPL3(1), RPS6KA2(1) | 189599 | 2 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
541 | HSA03020_RNA_POLYMERASE | Genes involved in RNA polymerase | 23 | POLR2A(1), POLR2G(1) | 192815 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 |
542 | RNA_POLYMERASE | 14 | POLR2A(1), POLR2G(1) | 193044 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1.00 | 1.00 | |
543 | HSA03010_RIBOSOME | Genes involved in ribosome | 67 | RPL3(1) | 131642 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
544 | ARAPPATHWAY | ADP-ribosylation factors (ARFs), members of the Ras superfamily, regulate eukaryotic vesicular trafficking and activate phospholipase D's. | 12 | ARFGAP3(1) | 191821 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1.00 | 1.00 |
545 | AHSPPATHWAY | Alpha-hemoglobin stabilizing protein (AHSP) prevents precitipation of hemoglobin alpha-subunits. | 12 | 50037 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
546 | ARFPATHWAY | Cyclin-dependent kinase inhibitor 2A is a tumor suppressor that induces G1 arrest and can activate the p53 pathway, leading to G2/M arrest. | 16 | 6997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
547 | ARGININECPATHWAY | Related catabolic pathways process arginine, histidine, glutamine, and proline through glutamate to alpha-ketoglutamate, which feeds into the citric acid cycle. | 6 | 38450 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
548 | ASBCELLPATHWAY | B cells require interaction with helper T cells to produce antigen-specific immunoglobulins as a key element of the human immune response. | 8 | 1440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
549 | BADPATHWAY | When phosphorylated, BAD is inhibited by sequestration; when non-phosphorylated, it promotes apoptosis by inactivating pro-survival BCL-XL and BCL-2. | 22 | 31076 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
550 | BETAOXIDATIONPATHWAY | Beta-Oxidation of Fatty Acids | 6 | 11560 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
551 | BLOOD_GROUP_GLYCOLIPID_ BIOSYNTHESIS_LACTOSERIES | 7 | 49565 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
552 | CDC25PATHWAY | The protein phosphatase Cdc25 is phosphorylated by Chk1 and activates Cdc2 to stimulate eukaryotic cells into M phase. | 7 | 65730 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
553 | CDK5PATHWAY | Cdk5, a regulatory kinase implicated in neuronal development, represses Mek1, which downregulates the MAP kinase pathway. | 12 | 29321 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
554 | CHONDROITIN | 8 | 9185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
555 | CTLA4PATHWAY | T cell activation requires interaction with an antigen-MHC-I complex on an antigen-presenting cell (APC), as well as CD28 interaction with the APC's CD80 or 86. | 17 | 1712 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
556 | EEA1PATHWAY | The FYVE-finger proteins EEA1 and HRS are localized to endosome membranes and regulate sorting and ubiquitination in the vesicle transport system. | 6 | 3000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
557 | EICOSANOID_SYNTHESIS | 17 | 13640 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
558 | EIF2PATHWAY | Eukaryotic initiation factor 2 (EIF2) initiates translation by transferring Met-tRNA to the 40S ribosome in a GTP-dependent process. | 9 | 33000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
559 | ERBB3PATHWAY | Neuregulins bind to the receptor tyrosine kinases ErbB3 and ErbB4, surface-localized receptors whose overexpression induces tumor formation. | 4 | 25080 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
560 | ETCPATHWAY | Energy is extracted from carbohydrates via oxidation and transferred to the mitochondrial electron transport chain, which couples ATP synthesis to the reduction of oxygen to water. | 9 | 44184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
561 | FBW7PATHWAY | Cyclin E interacts with cell cycle checkpoint kinase cdk2 to allow transcription of genes required for S phase, including transcription of additional cyclin E. | 8 | 5160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
562 | FIBRINOLYSISPATHWAY | Thrombin cleavage of fibrinogen results in rapid formation of fibrin threads that form a mesh to capture platelets and other blood cells into a clot. | 11 | 26981 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
563 | FREEPATHWAY | Neutrophils release superoxide to induce lysis in invading bacteria; in neighboring endothelial cells, superoxide dismutase scavenges radicals but produces pro-apoptotic peroxides. | 10 | 44201 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
564 | G2PATHWAY | Activated Cdc2-cyclin B kinase regulates the G2/M transition; DNA damage stimulates the DNA-PK/ATM/ATR kinases, which inactivate Cdc2. | 20 | 104335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
565 | GANGLIOSIDE_BIOSYNTHESIS | 8 | 9314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
566 | GATA3PATHWAY | GATA-3 is a transcription factor that promotes differentiation of helper T cells into Th2 cells, which secrete cytokines IL4, IL5, and IL13. | 16 | 1440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
567 | GLOBOSIDE_METABOLISM | 13 | 30314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
568 | GPCRDB_CLASS_A_RHODOPSIN_ LIKE2 | 13 | 90997 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
569 | HEME_BIOSYNTHESIS | 9 | 41061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
570 | HEPARAN_SULFATE_ BIOSYNTHESIS | 8 | 9185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
571 | HSA00363_BISPHENOL_ A_DEGRADATION | Genes involved in bisphenol A degradation | 14 | 38208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
572 | HSA00430_TAURINE_ AND_HYPOTAURINE_ METABOLISM | Genes involved in taurine and hypotaurine metabolism | 6 | 11880 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
573 | HSA00440_AMINOPHOSPHONATE_ METABOLISM | Genes involved in aminophosphonate metabolism | 16 | 27367 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
574 | HSA00460_CYANOAMINO_ ACID_METABOLISM | Genes involved in cyanoamino acid metabolism | 6 | 11500 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
575 | HSA00480_GLUTATHIONE_ METABOLISM | Genes involved in glutathione metabolism | 37 | 99683 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
576 | HSA00520_NUCLEOTIDE_ SUGARS_METABOLISM | Genes involved in nucleotide sugars metabolism | 6 | 2160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
577 | HSA00601_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_LACTOSERIES | Genes involved in glycosphingolipid biosynthesis - lactoseries | 10 | 33194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
578 | HSA00603_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_GLOBOSERIES | Genes involved in glycosphingolipid biosynthesis - globoseries | 14 | 21000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
579 | HSA00604_GLYCOSPHINGOLIPID_ BIOSYNTHESIS_GANGLIOSERIES | Genes involved in glycosphingolipid biosynthesis - ganglioseries | 16 | 21000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
580 | HSA00625_TETRACHLOROETHENE_ DEGRADATION | Genes involved in tetrachloroethene degradation | 7 | 19060 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
581 | HSA00626_NAPHTHALENE_ AND_ANTHRACENE_DEGRADATION | Genes involved in naphthalene and anthracene degradation | 18 | 43988 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
582 | HSA00642_ETHYLBENZENE_ DEGRADATION | Genes involved in ethylbenzene degradation | 12 | 42068 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
583 | HSA00730_THIAMINE_ METABOLISM | Genes involved in thiamine metabolism | 8 | 10320 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
584 | HSA00750_VITAMIN_ B6_METABOLISM | Genes involved in vitamin B6 metabolism | 5 | 13800 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
585 | HSA00791_ATRAZINE_ DEGRADATION | Genes involved in atrazine degradation | 9 | 67584 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
586 | HSA00900_TERPENOID_ BIOSYNTHESIS | Genes involved in terpenoid biosynthesis | 6 | 21960 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
587 | HSA04130_SNARE_INTERACTIONS_ IN_VESICULAR_TRANSPORT | Genes involved in SNARE interactions in vesicular transport | 35 | 51598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
588 | HYPERTROPHY_MODEL | 17 | 11972 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
589 | IGF1MTORPATHWAY | Growth factor IGF-1 activates AKT, Gsk3-beta, and mTOR to promote muscle hypertrophy. | 19 | 21856 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
590 | IL17PATHWAY | Activated T cells secrete IL-17, which stimulates fibroblasts and other cells to secrete inflammatory and hematopoietic cytokines. | 13 | 1712 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
591 | INFLAMPATHWAY | Interleukins and TNF serve as signals to coordinate the inflammatory response, in which macrophages recruit and activate neutrophils, fibroblasts, and T cells. | 29 | 1440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
592 | MITOCHONDRIAPATHWAY | Pro-apoptotic signaling induces mitochondria to release cytochrome c, which stimulates Apaf-1 to activate caspase 9. | 19 | 34761 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
593 | MITRPATHWAY | The MyoD/MEF2 transcription factors induce muscle cell differentiation and are repressed by the transcriptional repressor MITR. | 9 | 63951 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
594 | MONOAMINE_GPCRS | 32 | 105388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
595 | NUCLEOTIDE_SUGARS_ METABOLISM | 5 | 2160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
596 | N_GLYCAN_DEGRADATION | 13 | 117224 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
597 | P35ALZHEIMERSPATHWAY | p35, a neuron-specific activator of cyclin-dependent kinase 5, is cleaved to p25 in Alzheimer's disease and promotoes hyperphosphorylated tau formation and apoptosis. | 11 | 8879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
598 | PLK3PATHWAY | Active Plk3 phosphorylates CDC25c, blocking the G2/M transition, and phosphorylates p53 to induce apoptosis. | 6 | 12241 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
599 | PTC1PATHWAY | The binding of extracellular signaling protein Sonic hedgehog to the Patched receptor (Ptc1) allows progression through G1 and may inhibit the G2/M transition. | 9 | 34902 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
600 | RABPATHWAY | Rab family GTPases regulate vesicle transport, endocytosis and exocytosis, and vesicle docking via interactions with the rabphilins. | 9 | 58234 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
601 | RANKLPATHWAY | RANK is a TNF-type receptor that promotes osteoclast differentiation and consequent bone resorbtion on binding RANK ligand produced by osteoblasts. | 12 | 47183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
602 | RECKPATHWAY | RECK is a membrane-anchored inhibitor of matrix metalloproteinases, which are expressed by tumor cells and promote metastasis. | 9 | 4362 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
603 | REDUCTIVE_CARBOXYLATE_ CYCLE_CO2_FIXATION | 9 | 30840 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
604 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. | 6 | 10320 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
605 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. | 7 | 20573 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
606 | SA_PROGRAMMED_CELL_ DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. | 12 | 7401 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
607 | STEMPATHWAY | In the absence of infection, bone marrow stromal cells release hematopoietic cytokines; activated macrophages and Th cells induce hematopoiesis during infection. | 15 | 1440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
608 | TCAPOPTOSISPATHWAY | HIV infection upregulates Fas ligand in macrophages and CD4 in helper T cells, leading to widespread Fas-induced T cell apoptosis. | 6 | 1712 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
609 | TCRMOLECULE | T Cell Receptor and CD3 Complex | 3 | 1712 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
610 | TERCPATHWAY | hTERC, the RNA subunit of telomerase, and hTERT, the catalytic protein subunit, are required for telomerase activity and are overexpressed in many cancers. | 6 | 27723 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
611 | TERPENOID_BIOSYNTHESIS | 4 | 12840 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | ||
612 | TERTPATHWAY | hTERC, the RNA subunit of telomerase, and hTERT, the catalytic protein subunit, are required for telomerase activity and are overexpressed in many cancers. | 7 | 24730 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
613 | TOB1PATHWAY | TGF-beta signaling activates SMADs, which interact with intracellular Tob to maintain unstimulated T cells by repressing IL-2 expression. | 16 | 3152 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
614 | TUBBYPATHWAY | Tubby is activated by phospholipase C activity and hydrolysis of PIP2, after which it enters the nucleus and regulates transcription. | 6 | 101555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
615 | UREACYCLEPATHWAY | Ammonia released from amino acid deamination is used to produce carbamoyl phosphate, which is used to convert ornithine to citrulline, from which urea is eventually formed. | 5 | 5090 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
616 | UREA_CYCLE_AND_METABOLISM_ OF_AMINO_GROUPS | 19 | 34734 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 |
Notes: (Please see notes under significantly mutated gene table)